Airway progenitor cell development and function : mimicking in vivo behavior in vitro by Eenjes, E. (Evelien)
Airway Progenitor Cell Development 
and Function
Mimicking in vivo behavior in vitro
Evelien Eenjes
The work presented in this thesis was financially supported by the Sophia foundation 
for medical research [grant number S14-12] and a grant from The Netherlands 
Organization for Health Research and Development [ZonMW; grant #114021508].
The studies described in this thesis were performed at the department of Pediatric 
surgery in the Sophia Childrens Hospital, Rotterdam, The Netherlands.
Printing costs were supported by the Erasums University Rotterdam.
ISBN: 978-94-6375-848-2
Author: Evelien Eenjes
Cover design & Layout: Jan, Margreet en Evelien Eenjes
Printed by: Ridderprint
Copyright (C) Evelien Eenjes, 2020. All rights reserved. No part of this thesis may be 
reproduced, stored in a retrieval system, or transmitted in any form by any means, 
without prior written permission from the author.
Airway Progenitor Cell Development 
and Function
Mimicking in vivo behavior in vitro
Luchtweg voorloper cel ontwikkeling en functie
Nabootsen van in vivo gedrag in vitro
Proefschrift
ter verkrijging van de graad van doctor aan de 
Erasmus Universiteit Rotterdam
op gezag van de
rector magnificus
Prof. dr. R. C. M. E. Engels
en volgens besluit van het College voor Promoties.
De openbare verdediging zal plaatsvinden op
Woensdag 29 april 2020 om 15.30 uur
door
Evelien Eenjes
geboren te Groningen
Promotiecommisie
Promotor:  Prof. dr. D. Tibboel
Copromotor:  Dr. R. Rottier
Overige leden:  Prof. dr. N. Galjart
   Prof. dr. F. G. Grosveld
   Prof. dr. R. Gosens
Contents
Chapter 1.1        7  
Introduction
Scope of this thesis
Chapter 1.2        25 
Regeneration of the lung: lung stem cells and the development of lung 
mimicking devices
Chapter 2        53
A novel method for expansion and differentiation of mouse tracheal 
epithelial cells in culture
Chapter 3        79
Disease modelling following organoid-based expansion of airway 
epithelial cells
Chapter 4         107 
SOX21 modulates SOX2-initiated differentiation of epithelial cells in 
the extrapulmonary airways
Chapter 5        143 
Distinct roles for SOX2 and SOX21 in differentiation, distribution and 
maturation of pulmonary neuroendocrine cells
Chapter 6        159 
General discussion        
Appendix        177  
Summary / Samenvatting
Curriculum Vitae
List of publications
PHD Portfolio
Acknowledgements / Dankwoord

Chapter 1.1 
Introduction
Scope of this thesis
Chapter 1.18
Introduction 9
The lung is composed of a highly branched airway structure, which humidifies and 
warms the air before entering the alveolar compartment. In the alveoli, a thin layer 
of epithelium is in close proximity with the capillary endothelium, allowing for an 
efficient exchange of oxygen and carbon dioxide. During development proliferation 
and differentiation of progenitor cells generates the lung architecture, and in the 
adult lung a proper function of progenitor cells is needed to regenerate after injury. 
Malfunctioning of progenitors during development results in various congenital lung 
disorders, like Congenital Diaphragmatic Hernia (CDH) and Congenital Pulmonary 
Adenomatoid Malformation (CPAM). In addition, many premature newborns 
experience continuous insults on the lung caused by artificial ventilation and 
supplemental oxygen, which requires a highly controlled mechanism of airway repair. 
Malfunctioning of airway progenitors during regeneration can result in reduction of 
respiratory function or (chronic) airway diseases. It is hypothesized that pathways 
that are active during development are re-activated upon damage, or at least in part. 
Understanding basic mechanisms of progenitor cell behavior during development, 
and regeneration can help to gain a better understanding about the underlying 
cause of lung diseases, especially those occurring in prenatal development or in the 
immediate postnatal period of life. 
 
LUNG DEVELOPMENT 
After fertilization, many cell fate decisions are made to evolve from a one-cell 
embryo to a full-grown organism with optimal lung function at birth. Each cell 
fate decision is tightly regulated and closely monitored, from the segregation into 
ectoderm, mesoderm and endoderm, till the late commitment towards lung specific 
cell types. The trachea, airway, and alveolar epithelial cells of the lung, develop 
from the endodermal lineage. Simultaneously with lung endodermal development, 
the lung mesoderm develops and generates various cell lineages such as vascular 
cells, smooth muscle cells, pericytes and cartilage precursors. The lung mesoderm 
and endoderm promote each other’s growth and differentiation during all stages of 
development [1, 2]. Here, we focus on the development of lung epithelium out of 
endodermal progenitors.  
Origin and specification of the lung  
Specification of lung and esophagus starts from the anterior foregut endoderm. A 
dorsalventral (D-V) patterning of the foregut, separates dorsal, Sry-related HMG 
box 2 positive (SOX2+) esophagus progenitors from ventral, NK2 Homeobox 
1 positive (NKX2-1+) lung progenitors [3, 4] (for details see Fig. 1). Multiple 
reciprocal signaling cues between mesoderm and endoderm that contribute to 
a proper localization of Nkx2-1 expression in the ventral foregut endoderm have 
been identified (Fig. 1) [2, 5, 6]. Two main events are important, the initiation of 
Nkx2-1 expression and repression of Sox2. First, Nkx2-1 expression is induced 
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by both canonical WNT2 and WNT2b ligands from the ventral mesoderm and FGF2 
secretion from adjacent developing cardiac mesoderm [7-9]. Second, the repression 
of Sox2 in the ventral foregut endoderm is due to the expression of Bmp4 from the 
ventral mesoderm [10]. NOGGIN is secreted by cells residing in the notochord on 
the dorsal side, suppressing BMP signaling in de dorsal mesoderm and allowing 
Sox2 expression [11, 12]. SOX2, in its turn, is able to repress Nkx2-1 expression, 
thereby restricting its expression to the ventral foregut endoderm [10] (Fig. 1). 
The expression of Sox2 and Nkx2-1 demarcating the D-V boundary of the foregut 
endoderm is important in separating the trachea from the esophagus. Mouse models 
with expression levels of Sox2 below a 15% threshold or lacking Nkx2-1, both 
resulted in separation defects, resembling the human congenital condition called 
tracheoesophageal fistula (TEF), where the airway is connected with the stomach 
and/or esophageal atresia (EA), a short and blunted esophagus [3, 4, 11]. Multiple 
factors that contribute to trachea and esophagus D-V patterning have been identified 
using genetic mouse models resembling a TEF/EA phenotype, or with genetic 
screens of human infants born with EA/TEF (Fig. 1, Table 1) [5, 11]. Although genetic 
analyses of human EA/TEF patients and animal models revealed genes associated 
with EA/TEF, the cellular mechanisms causing the separation defect are poorly 
understood.
Fig. 1. Proteins involved in lung specification. During lung specification, Nkx2-1 expression is restricted to the 
ventral side and Sox2 to the dorsal side of the foregut endoderm. Retinoic acid (RA)-signaling activates RA receptors 
in the surrounding mesoderm driving cells to secrete Sonic Hedgehog (SHH) (HH ligand) in the ventral foregut 
mesoderm. SHH-responsive cells subsequently trigger activation of GLI2 and GLI3 transcription factors in the ventral 
mesoderm, which stimulate expression of WNT2/2b and BMP4 [89]. Odd-skipped related zinc finger transcriptional 
repressor, OSR, and SHH signaling target TBX5 are important modulators of WNT2/2b and BMP4 signaling [90, 91]. 
The transcription factor, BARX1, is expressed in the dorsal mesenchyme thereby repressing WNT signaling [83].
Table 1. Mutations in genes associated with defects in tracheoesophageal development in mouse and human. 
The contribution of these genes listed have shown to play a role in the specification of lung progenitors and  their 
involvement is indicated in figure 1. TEF = tracheoesophagel fistula, EA = esophageal atresia.
Notochord
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NKX2-1
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WNT2/2b
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Trachea and primary lung bud formation 
After specification of lung progenitors, the single common foregut tube begins to 
compartmentalize [1]. A timed and localized expression of retinoic acid (RA) induces 
mesenchymal expression of FGF10, which activates NKX2-1+ lung progenitor cells 
by binding to its receptor FGFR2B and subsequently induces lung bud formation 
[13-15] (Fig. 2). At the same time of lung bud formation, the trachea, separates from 
the esophagus proximal of the lung buds [11, 16]. Of note, FGF10 knock out mice 
show normal formation of the trachea, while the lung buds do not form [17, 18], 
suggesting that a distinct mechanism of FGF10 signaling is involved in formation 
and separation of the trachea from the esophagus. 
Fig. 2. Primary lung bud formation FGF10 from the ventral 
mesoderm is essential in lung bud formation, and is regulated 
by RA and Transforming Growth Factor-β (TGF-β) signaling. 
TBX transcription factors present in the foregut mesoderm 
have shown to be essential in regulating FGF10 expression as 
well [92, 93]. E = embryonic day, pcw = post-conceptional week
NKX2-1
FGF10
TBX 4/5
RA
TGFB
FGFR2B
E 9.5
pcw ~4-6
Branching Morphogenesis  
A complex tree-like structure of airways is formed in the pseudoglandular stage, 
with a repetitive pattern of formation of new buds, bifurcation and outgrowth of 
buds [19]. During branching of the airways SOX9+, Inhibitors of DNA binding 2+ 
progenitor cells (ID2+)  reside at the branching distal tips. These tip progenitors, 
are multipotent and give rise to the SOX2+ progenitor cells which will form 
the airway epithelium [20-22]. In contrast to the mouse branching airways, in 
human lung the tip progenitors express both SOX9 and SOX2 (Fig. 4A) [23, 24].
Maintaining a proximal-distal patterning during lung development is crucial for a 
proper branching of the airways. We previously illustrated formation of cystic airway 
structures in a mouse model where Sox2 expression was induced in the distal tip 
progenitor cells [20]. During the last decades, the use of transgenic mouse models 
contributed highly to the identification of multiple epithelial-mesenchymal signaling 
pathways important for maintaining a proximal-distal patterning and coordinating 
initiation and outgrowth of lung buds (for further references [1, 25] and the legend of 
Fig. 3). As described, FGF10 is a major player in primary bud formation, and FGF10 
continues to be present in the mesenchyme surrounding the outgrowing buds 
during branching morphogenesis [17, 26]. The localized source of FGF10 within the 
“tipmicroenvironment” regulates multiple factors to control expansion of the bud by 
inducing proliferation while suppressing Sox2 expression to prevent differentiation 
(Fig. 3) [27-30]. When the lung bud grows, cells become displaced from the FGF10 
source and differentiate to SOX2+ airway progenitor cells. FGF10 plays a central 
role in the branching morphogenesis of mouse lungs, however, FGF10 is not 
essential for branching of human fetal lungs in vitro [31]. Further studies are needed 
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to elucidate the differences and similarities in molecular mechanisms controlling 
mouse and human proximal-distal patterning. This will help to reveal the mechanisms 
of abnormal development, which give rise to a variety of life threatening congenital 
anomalies, such as CDH, CPAM and EA/TEF.  Defects or interruptions in these 
signaling and gene expression pathways, like Sox2 overexpression, have shown 
to lead to branching defects resembling the congenital lung disease, CPAM [20]. 
Despite, the strong correlation between SOX2 and the formation of airway cysts, it is 
not known how SOX2 exerts its activity.
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Fig. 3. Lung bud outgrowth (A) Several reciprocal 
interactions between mesoderm and endoderm 
regulate the expansion of the distal tip through 
proliferation and suppression of Sox2 expression. 
SHH is expressed in a gradient with the highest 
expression in the distal bud. SHH inhibits 
mesenchymal FGF10 expression just proximal of 
the distal bud. At high concentrations, SHH induces 
expression of HH inhibitory protein (HHIP) in the 
distal mesenchyme to allow for FGF10 expression 
via regulation of GLI3 and FOXF1 [25]. Proliferation 
of progenitor cells is positively regulated via 
BMP4 induction or inhibited via its antagonist 
SPRY2 [29, 94-96]. Sox2 expression is inhibited 
via Wnt-β-Catenin and BMP4 signaling [28, 30]. 
(B) Knock-out mouse models of WNT ligands 
demonstrated defects in lung development; 
WNT2/2b(canonical) [97] in distal mesenchyme, 
WNT5a (non-canonical) [98-100] and WNT7b 
(canonical) in distal epithelium [101], each suggested 
to be involved in the regulation of BMP4, β-Catenin, 
SHH signaling or cell proliferation.  ⟳= proliferation.
Development of proximal airway and distal alveolar lineages 
During branching morphogenesis, SOX2+ progenitor cells proliferate but also 
start to differentiate to proximal airway cell lineages (Fig. 2B). SOX2 remains in 
airway epithelium after progenitor cells differentiate, and deletion of SOX2 during 
development shows a severe reduction in basal, ciliated and secretory cells [21].  
The fi rst evidence of differentiation is the appearance of a few basal cells 
(Transformationrelated protein 63, TRP63+) at E9.5 in the trachea and in proximal 
regions of the lung bud in mice. Lineage tracing studies using Trp63-CreERT, shows 
that basal cells at <E9.5 are able to give rise to both airway and alveolar epithelial 
cells (Fig. 4B). From E10.5 onward, basal cells are only progenitors for the cells in 
the pseudostratifi ed epithelium of the extrapulmonary airways (trachea and main 
bronchi) [32] (Fig. 4B). Vice versa, lineage tracing of tip progenitor cells using Sox9-
Cre or Id2-Cre induced at <E9.5, shows that tip progenitor cells give rise to airway 
epithelial cells both in the extra- and intra-pulmonary airways, and lineage tracing of 
SOX9+ or ID2+ progenitors from E11.5 shows that tip progenitor cells only give rise 
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Fig. 4. Endodermal lineage 
specification during lung 
development. (A) A proximal-
distal patterning of the lung bud 
regionalizes the airway epithelium 
during branching. In human, distal 
bud progenitor cells express SOX9 
and SOX2, while in mice these 
cells only express Sox9. After the 
pseudoglandular stage, SOX9+ 
progenitors are present in the tip of 
the distal bud, SOX2- SOX9- just 
proximal of the distal bud and SOX2+ 
progenitors in the proximal airways. In 
mice, the patterning of the distal bud 
is further specified by the expression 
of Sftpc and Hopx. (B) During the 
growth of the primary lung buds a, 
SOX9+ progenitor cells give rise to 
the SOX2+ airway progenitor and a 
few basal cells are present. Some 
SOX9+ progenitors start to specify 
to alveolar type (AT) I or ATII cells 
around E13.5. SOX2+ progenitors 
differentiate to neuroendocrine cells 
(NE) and basal cells. The basal cells 
that develop at this stage, can self-
renew and differentiate to ciliated and 
secretory cells in the extrapulmonary 
airways. SOX2+ progenitor cells 
also further differentiate to secretory 
and ciliated cells. Secretory cells 
can self-renew and give rise to 
ciliated cells [63]. Notch signaling 
inhibits or stimulates differention at 
different stages of lung development. 
During the canalicular and saccular 
stage, numerous alveolar sacs develop 
that are the precursors of the alveoli. 
SFTPC+SOX9+, SFTPC+PDPN+ 
and HOPX+ progenitor cells further differentiate into ATI or ATII cells. At the end of embryonic lung development, 
the alveolar sacs are subdivided by the formation of secondary septae and the ATI cells become closely associated 
with the endothelial cells [25].   ⤼ cell division, E = embryonic day, pcw = post-conceptional week, PN = post-natal.
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to the intrapulmonary airways [22, 32]. Thus, during lung specification and lung bud 
formation (E8.5-E9.5), two complementary lineages are defined early in trachea/
lung development, both contributing to the epithelial cells of the respiratory tract.  
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B. EPITHELIAL CELL SPECIFICATION
A. PROXIMAL-DISTAL PATTERNING
1.1
At E13.5, as the bronchial tree is expanding, SOX2+ progenitor cells give rise to 
Neuroendocrine (NE) cells and non-NE cells (Fig. 2B). Precursor of NE cells, are 
first scattered throughout the proximal airway epithelium and subsequently migrate 
to form NE clusters, which are mostly located at the bifurcations of airways [33, 
34]. Notch activity controls the choice between NE and non-NE cell fate [35, 36]. 
Inhibition of Notch signaling results in an increase in NE cells, but also in an increase 
in ciliated cells at the expense of secretory cells. This shows that  Notch signaling 
balances the differentiation between secretory and ciliated cells at later stages in 
development (after E15.5) (Fig. 4B) [37-39]. NE cell hyperplasia is associated with 
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CDH, but the underlying cause  and whether this contributes to the onset or specific 
pathology related to CDH is not yet investigated [40]. Previously, it was shown that 
overexpression of Sox2 during lung development resulted in increased basal cell 
numbers, but also to an increase in NE cells. However, the underlying molecular 
mechanisms that guide the SOX2+ airway progenitors to differentiate to basal or NE 
cells is not yet understood [20]. 
Mature alveoli exist of cuboidal surfactant producing alveolar type 2 cells (ATII) and 
flattened alveolar type I (ATI) cells. The first specification of SOX9+ tip progenitors 
to either ATI or ATII cells is observed at E13.5 [41] (Fig. 4A, B). From E15.5 onward, 
SOX9+ progenitors are still involved in branching of distal tips, but cells in the recently 
branched epithelium do not express Sox2, as they do early in development, but rather 
express the ATI marker, Hopx (Fig. 4A) [41, 42]. In addition, bipotent progenitor cells 
expressing both ATII and ATI markers, can be found in the distal bud but they show 
only minor contribution to the alveolar compartment during development [41, 43, 
44] (Fig 4B). In human lung development, tip progenitors loose SOX2 expression 
and remain only SOX9+ in the canalicular and saccular stage (Fig. 4A). However, 
tip progenitor cells already start to express both markers of ATI and ATII cells 5 
weeks prior to the canalicular stage and in co-expression with SOX2 [23]. The 
functional significance of SOX2 expression in human tip progenitor cells during the 
pseudoglandular stage is currently unknown.
LINEAGE DIVERSIFICATION AND CELL PLASTICITY UPON AIRWAY 
REGENERATION 
As a result of lung development, the airway epithelium is aligned with a wide range 
of cell types (Fig. 5). During steady state, the airway epithelium is a low turnover 
tissue, but upon severe damage, quiescent progenitor cells can regenerate the 
airway epithelium. An imbalance in homeostatic turnover or regeneration, can cause 
severe lung diseases like, Bronchopulmonary Dysplasia (BPD), Chronic Obstructive 
Pulmonary Disease (COPD), asthma or lung cancers. Lineage tracing studies in mice 
have demonstrated that within the airway epithelium, most adult epithelial cells retain 
plasticity to de- or transdifferentiate under stress or damage conditions. Ciliated cells 
are an exception, they have no potential to proliferate or differentiate after injury 
[37]. Here, a focus is made on the main adult airway cell types that are known to 
contribute to repair after injury. A more extensive description of lung regeneration 
and in vitro models to study adult airway epithelium is given in our published review 
(chapter 1.2;[45]).
Basal cells 
The basal cell is one of the most studied cell types of the lung regarding regeneration. 
In the mouse, basal cells are mainly located in the extrapulmonary airway epithelium. 
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In the human lung, basal cells are present in the trachea to the smallest airways 
and are only absent in the terminal bronchioles just proximal of the alveoli (Fig. 5) 
[46]. In vitro cultures using isolated mouse and human basal cells have shown that 
these cells can self-renew and are multipotent, meaning that they can differentiate to 
secretory and ciliated cells [47].  
In both, mouse and human, basal cells are characterized by the expression of Trp63, 
and Trp63 knock-out mice lack basal cells [48-50]. Besides Trp63 expression, all 
basal cells also express Cytokeratin 5 (Krt5), while a subpopulation of basal cells 
express Cytokeratin 14 (Krt14), which greatly expands upon injury [51, 52]. In 
human airway epithelium,  KRT14  also shows a more restricted expression pattern 
than KRT5, but increases in regions of squamous metaplasia in COPD patients 
[46]. The functional difference between KRT14+ and KRT14- basal cells is not yet 
explored. Furthermore, basal cells are thought to be the source of lung squamous 
cell carcinoma through increased expression of both SOX2 and TRP63 [53, 54]. The 
regulation of basal cell maintenance, proliferation and differentiation in relation to 
SOX2 is poorly understood. 
A very small population of Trp63 expressing cells reside in the mouse intrapulmonary 
airways, which substantially increases upon severe lung injury. Lineage tracing 
showed that these cells contributed to both alveolar and airway lineages, showing 
the high potential of distal TRP63+ cell population to regenerate lung epithelium 
[32, 55, 56]. Although, a similar population of basal cells was identified in human 
terminal bronchioles, its expansion or differentiation potential and contribution to 
airway regeneration is still uncertain [55].
Submucosal glands 
Submucosal glands (SMGs) are specialized secretory glands with a grape like 
structure embedded within the connective tissue, just underneath the proximal 
tracheal epithelium of the mouse and the cartilaginous airways of the human [57] (Fig. 
5). The submucosal glands can be subdivided in ducts and acini. The ducts contain a 
similar cellular composition as the surface epithelium of the airways. The acini contain 
basally located myoepithelial cells expressing Krt14, Krt5 and smooth muscle actin 2 
(Acta2), and luminal cells secreting mucous and fluids rich in antimicrobial enzymes 
[58, 59]. Upon injury, basal myoepithelial cells migrate to the surface epithelium of 
the trachea and aid in repopulating the airway due to proliferation and differentiation 
to basal, ciliated and secretory cells [60, 61]. In pigs, similar to human, SMGs are 
present throughout the cartilaginous airways and exposure to chlorine gas showed 
that SMG derived cells contributed to the repair of the airway [61]. 
Secretory cells
Secretory (Club) cells produce mucins and microbial peptides to capture inhaled 
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substances, which are propelled out of the lung through cilia movement. Different 
subsets of secretory cells in mouse and human airways are identified by the secretion 
of different members of secretoglobins; SCGB1A1, SCGB3A1 or SCGB3A2 [62] 
(Fig. 5). Lineage tracing studies, using secretory cell marker SCGB1A1, showed 
that besides the protective function, secretory cells have the potency to self-renew, 
differentiate to ciliated cells, and de- differentiate to basal cells [63, 64].  
Naphthalene-induced injury is a common used mouse model to study airway 
regeneration [65]. Secretory cells are most vulnerable to naphthalene exposure 
due to their expression of Cytrochrome P450 enzyme (Cyp2f2), which converts 
naphthalene to a cytotoxic product [66]. A subset of secretory cells, the variant club 
cells, was identified because they lack Cyp2f2 expression, and survive naphthalene 
exposure [67, 68]. The variant club cell is located closely to neuroendocrine cell 
clusters, and expresses Uroplakin3a (UPK3a) [69] in addition to Scgb1a1 (Fig. 5). 
A similar localization of UPK3a+ secretory cells near neuroendocrine cells was 
observed in human lung sections, suggesting a similar progenitor cell population is 
present [69]. 
Neuroendocrine cells 
The neuroendocrine (NE) cells form a rare subpopulation in the airway epithelium 
and act as chemosensory cells, communicating with the nervous system and 
influencing smooth muscle tone as well as regulating immune responses [70-72]. NE 
cells also have the ability to contribute to airway epithelial repair after naphthalene 
induced injury [73, 74]. As mentioned, hyperplasia of NE cells has been implicated 
in a number of lung diseases, some of which are pediatric lung diseases, like BPD 
and CDH [40, 75]. Furthermore, NE cell markers are found in small cell lung cancer 
(SCLC) [76], and in vivo studies in mouse showed the NE cells are the origin for 
SCLC development [73, 74]. How and why NE cells associate with such a wide 
range of lung diseases is unknown and therefore an interesting airway population 
to study. 
Bronchioalveolar stem cells 
In the zone where bronchiole transition to the alveoli, there are epithelial cells which 
carry both the secretory cell marker SCGB1A1 and ATII marker SFTPC [77] (Fig. 
5). These, so called Broncho-Alveolar Stem Cells (BASCs), show self-renewal 
potential and are able to differentiate to bronchiolar and alveolar cell types in vitro 
[77-79]. A novel dual-lineage tracing approach, showed that SFTPC+ SCGB1A1+ 
cells contribute to bronchiolar and alveolar epithelium after naphthalene-induced 
airway injury or bleomycin-induced alveolar injury, respectively [80, 81]. BASCs are 
relatively stable in normal lung homeostasis, showing that BASCs are only activated 
upon injury [80, 81]. In addition, lineage tracing studies using Scgb1a1-Cre showed 
Introduction 17
Fig. 5. Cellular composition of the airways.The extrapulmonary epithelium (trachea and main 
bronchi) of the mouse consists of a pseudostratified epithelium containing basal cells, while in the 
human lung, basal cells are only absent in the bronchioles proximal of the alveoli. Submucosal 
glands are in mouse and human only present in cartilaginous airways. The airway epithelium 
consists of many different epithelial cells, the main epithelial cells are described within the text. 
A rare epithelial cell type is the ionocyte. They appear to be the main source of cystic fibrosis 
transmembrane conductance regulator (CFTR) activity, thereby regulating mucous production [102]. 
Goblet cells are nearly absent in mouse airway epithelium, but are more frequently found in human 
airway epithelium and together with other secretory cells are responsible for mucous production.
TRP63+
KRT5+
Basal
ASCL1+
CGRP+
NE / NE cluster
FOXJ1+
Cilia
SCGB1A1+ /
SCGB3A1+ /
SCGB3A2+
Secretory (Club)
FOXI1+
Tuft
AIRWAY EPITHELIAL CELLS
Cartilage
Extrapulmonary airways
Extra- and Intrapulmonary airways Bronchioles
Intrapulmonary airways
SCGB1A1+ /
UP3KA+
Variant Club
MUC5AC+
Goblet
SCGB1A1+
SFTPC+
BASC
Submucosal
Gland
SMG EPITHELIAL CELLS
KRT5+ /ACTA2+
Myoepithelial
LTF+
Serous
MUC5B+
Mucous
1.1
that; SCGB1A1+ cells did not contribute to alveolar repair after hyperoxic aveolar 
injury  [63], suggesting that the contribution of SCGB1A1+ cells to alveolar repair 
depends on the type and possibly severity of injury.
In conclusion, airway epithelial cells have the ability to regenerate the airway 
epithelium. The contribution to this by different cell types can be assessed by the 
use of lineage tracing tools and different injury models. However, the identification 
of progenitor lineages is much easier and faster than understanding the underlying 
mechanisms that regulate the contribution of each cell type to regeneration. 
Furthermore, most of the airway epithelial cell plasticity is observed in mouse 
models, translating these findings to either the quiescent human airway epithelium 
or the misregulation of cellular plasticity upon disease is a considerable challenge. 
Importantly, the proliferation of in vitro lung development models, such as lung 
organoids, air-liquid interphase cultures and lung-on-a-chip model, are likely to 
increase our understanding of human airway plasticity in development, homeostasis 
and disease.    
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SCOPE OF THIS THESIS 
During the development and regeneration of the airways, a proper maintenance, 
expansion and differentiation of progenitor cells is needed for proper lung formation 
and correct repair. Prior studies, highlighted the importance of SOX2 in airway 
progenitor function. In this thesis, the role of SOX2 in murine and human airway 
development and regeneration is investiged. As part of this, in vitro airway models 
are developed to translate our findings to human airway functions. In chapter 2, 
a focus is on the development of the expansion of basal cells in vitro to reduce 
the number of mice needed for air-liquid interface (ALI) cultures. In this manner, 
basal cell differentiation can be studied in vitro from mouse models that require 
intensive breeding strategies to obtain sufficient numbers of mice and cells. Chapter 
3 describes the development of a human in vitro airway model using available lung 
material. This will allow translation of findings obtained by in vitro mouse studies 
or in vivo mouse models to human airway progenitor functions in health and 
diseases. The clinical samples used contain low numbers of airway epithelial cells 
and therefore the possibility is assessed of expanding these cells as organoids to 
study the differentiation of basal cells on subsequent ALI culture. ALI cultures are air-
exposed and therefore an interesting model for air exposure studies, like cigarette 
smoke. Furthermore, with the use of tracheal aspirates of neonates, a human airway 
in vitro model is developed to study airway epithelial function of premature newborns 
that have the potential to develop bronchopulmonary dysplasia (BPD). Chapter 4 
elaborates on SOX2+ airway epithelial cells that specifically express SOX21 during 
development and regeneration. SOX2 and SOX21 function together in maintenance, 
proliferation and differentiation of stem cells during neuronal development, as well 
as in embryonic stem cells. Therefore, differentiation during lung development 
and repair after naphthalene injury is studied in mouse models deficient in SOX2 
or SOX21. Additionally, the expression of SOX21 is studied in human airways by 
using fetal lung organoids and ALI cultures of adult bronchial epithelial cells. As 
published previously, increased Sox2 expression during lung development results in 
neuroendocrine (NE) cell hyperplasia, which is often observed in airway diseases. 
Chapter 5 focusses on the potential role of SOX2 and SOX21 in the initiation, 
differentiation, migration and clustering of NE cells. Finally, chapter 6 dicusses the 
findings made in this thesis, future perspectives and contributions to the field.
Taken together, this thesis aims to increase the understanding of airway progenitor 
cell behavior during development and regeneration in both human and mouse by 
developing novel in vitro models. In understanding basic mechanisms of progenitor 
cell behavior, we hope to identify therapeutic targets when airway progenitor behavior 
goes awry resulting in disease. 
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ABSTRACT
Inspired by the increasing burden of lung associated diseases in society and 
an growing demand to accommodate patients, great efforts by the scientific 
community produce an increasing stream of data that are focused on delineating 
the basic principles of lung development and growth, as well as understanding the 
biomechanical properties to build artificial lung devices. In addition, the continuing 
efforts to better define the disease origin, progression and pathology by basic 
scientists and clinicians contributes to insights in the basic principles of lung biology. 
However, the use of different model systems, experimental approaches and readout 
systems may generate somewhat conflicting or contradictory results. In an effort 
to summarize the latest developments in the lung epithelial stem cell biology, we 
provide an overview of the current status of the field. We first describe the different 
stem cells, or progenitor cells, residing in the homeostatic lung. Next, we focus on 
the plasticity of the different cell types upon several injury-induced activation or repair 
models, and highlight the regenerative capacity of lung cells. Lastly, we summarize 
the generation of lung mimics, such as air-liquid interface cultures, organoids 
and lung on a chip, that are required to test emerging hypotheses. Moreover, 
the increasing collaboration between distinct specializations will contribute to the 
eventual development of an artificial lung device capable of assisting reduced lung 
function and capacity in human patients.
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BACKGROUND
Although the lung has a low rate of cellular turnover during homeostasis, it has a 
remarkable ability to regenerate cells after injury [1]. Disruption of this regeneration 
potential is the cause of several lung diseases. Therefore, understanding the 
underlying mechanisms of the regenerative capacity of the lung offers potential 
in identifying novel therapeutic targets. Much can be learned from studies on lung 
development as processes involved in the differentiation of cell lineages during 
development are recapitulated during repair [2]. Recent advances in the identification 
of new cell markers, the analysis of cell fate by in vivo lineage tracing experiments, the 
use of embryonic and induced pluripotent stem cells, and improvements in organoid 
cultures have increased the knowledge about the presence of potential stem cells 
in the lung [3-6]. The goal of this review is to survey the latest developments in 
endogenous lung regeneration and bioengineering of lung models for therapeutic 
applications in the future. We will first provide an overview of the latest insights 
in lung progenitor cells and their potential to differentiate into lung epithelial cells, 
which is of interest for the in vivo regeneration of lung tissue. Next, we will discuss 
the plasticity of the different epithelial cells in the lung and their potential to contribute 
to epithelial regeneration. Finally, we will highlight the possible clinical applications 
of this knowledge, focusing on different populations of stem cells, lung mimics and 
tissue engineering. 
POTENTIAL EPITHELIAL STEM CELLS OF THE LUNG
Different subsets of epithelial cells and potential stem cell niches have been 
identified in the lung. The airways of the human lung are lined by a pseudostratified 
epithelium made up of basal cells, secretory cells (Scgb1a1+ club cells and goblet 
cells), ciliated cells and neuroendocrine cells (Fig. 1A). The trachea of the mouse, a 
frequently used model in research, has a similar architecture as the human airways. 
In human airways, basal cells decrease in frequency from the large to the distal 
airways [7]. The airways of the mouse and the respiratory smallest bronchioles of the 
human lung are covered by a cuboidal epithelium. This epithelium lacks basal cells 
and contains ciliated cells, secretory cells and neuroendocrine cells that are usually 
clustered in neuroendocrine bodies (NEBs) (Fig. 2A) [8]. The alveoli of both human 
and mouse are composed of two functional distinct cell types, flat and extended 
alveolar type I (AT-I) cells to allow gas exchange and cuboidal alveolar type II (AT-II) 
cells for surfactant protein production and secretion (Fig. 2A) [2, 9]. New emerging 
technologies, such as single cell RNA-sequencing and proteomic analysis, revealed 
molecular signatures that hint at different subpopulations of type I and type II cells. It 
remains to be seen whether such signatures reflect functionally different cell types, 
or that it represents similar cells at physiologically or metabolically different phases. 
However interesting, this is not the focus of this review, and therefore we only refer 
to the current literature [10-12].
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Fig. 1. Regeneration of  pseudostratified airway epithelium of the lung. (A) The airways are lined by a 
pseudostratified epithelium consisting of secretory cells (goblet and club cells), ciliated cells, neuroendocrine cells 
and basal cells. Goblet cells are abundant in the human epithelium, but are rare in mice. (B) The relationship between 
the different epithelial cells during normal homeostasis. The basal cells are progenitor cells of the pseudostratified 
epithelium which are heterogeneous for the expression of Krt14. The basal cell becomes a Krt8 positive luminal 
precursor cell before further differentiation. A basal cell differentiate into secretory cells and neuroendocrine cells 
under homeostatic conditions. Neuroendocrine cells are also capable to self-renew  [168]. Scgb1a1+ secretory cells 
are a self-renewing population and can give rise to ciliated cells. In homeostatic epithelium, there is a very low turnover 
of cells. It is likely that the dividing secretory cell population is sufficient to regenerate ciliated cells in homeostatic 
condition. However, their generation from basal cells is not excluded. Upon allergen exposure, secretory cells are 
the main source of goblet cells [169], but it is unknown whether basal cells can directly differentiate into goblet cells. 
(C) Upon depletion of luminal cells by SO2exposure, basal cells proliferate and subdivide into two populations, 
N2ICD and c-myb positive, respectively, differentiating into secretory and ciliated cells. After the loss of basal cells, 
secretory cells (de)differentiate into functional progenitor basal stem cells. In a normal pseudostratified epithelium, 
only a few scattered goblet cells are present. Increases in goblet cells are observed upon immune stimuli and in 
diseases like COPD. Lineage tracing studies show that goblet cells can arise from Scgb1a1+ secretory cells and 
recently a trans-differentiation of Foxj1+ ciliated cells to goblet cells was observed upon smoke exposure in culture.
Basal-like stem cells: the stem cells of the epithelium
Basal cells are being characterized by the expression of Trp63, Ngfr, Podoplanin 
(Pdpn, also known as T1α), GSIβ4 lectin and Cytokeratin5 (Krt5). They have 
the capacity to self-renew and to form secretory and ciliated cells (Fig. 1B) [13-
15]. Notch signaling plays a major role in determining the differentiation of 
basal cells to either the secretory lineage or the ciliated lineage [15-17]. A 
small subset of the basal cells (<20%) expresses Krt14 under homeostatic
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conditions. These cells are thought to be a self-renewing population involved in 
maintenance of the Krt5+ basal cell population. This proportion is highly increased 
and becomes multipotent after naphthalene-induced depletion of secretory cells 
[18, 19]. Lineage tracing studies show that Krt14+ cells can directly regenerate 
secretory and ciliated cells [18, 20]. Recently, two distinct populations of basal cells 
were identified in the adult lung using long-term lineage tracing experiments and 
single-cell gene expression profiling: basal stem cells (BSCs) and basal luminal 
precursor cells (BLPCs). Both cell types are Krt5+ and Trp63+ with rare detection 
of Krt14, indicating that Krt14 is not a robust marker for stem cell identity [21]. 
However, the rapid up-regulation of Krt14 post-injury suggests that Krt14 may be 
an important marker to identify activated stem cells in the regenerating epithelium. 
Within homeostatic conditions, BSCs divide via asymmetric division to produce one 
new BSC and one BLPC, which can further differentiate into a neuro-endocrine and 
secretory cell (Fig. 1B). The BLPCs have a low or negligible rate of self-amplification, 
lack any overt signs of differentiation, and are distinct from BSCs by their expression 
of Krt8 [21]. This model is consistent with a previous observation in human basal 
cells addressing the potential of individual basal cells to self-renew and differentiate 
[22]. Additionally, the emergence of a Krt5+/Krt8+ parabasal cell population, which 
have comparable characteristics as the previously described BLPCs, was shown to 
be controlled by active Notch3 signaling [16]. Notch3-/- mice showed an increase in 
basal cells and parabasal cells, but not in multiciliated and secretory cells, suggesting 
that Notch3 is involved in restricting the expansion of the basal and parabasal 
population [16]. Interestingly, binding of the transcription factor Grainyhead-like 2 
(Grhl2) to the promotor region of Notch3 was observed, suggesting a role for Grhl2 
in the transcription of Notch3 [23]. BSC-specific ablation of Grhl2 showed only a 
decrease in the number of ciliated cells, but no other changes in the morphology of 
the epithelium [24]. Whether Grhl2 is important in the Notch3 dependent regulation 
of the BSC and parabasal cell population still has to be explored. Krt8+/Krt5+ double 
positive cells were previously identified in mice as a marker for  progenitor cells 
upon regeneration following injury induced by reactive oxygen species and sulfur 
dioxide (SO2) [15, 25]. Interestingly, using the SO2 injury model, it was observed 
that Trp63+ basal cell populations segregate in subpopulations prior to the formation 
of the Krt8+ progenitor cell. These dividing Trp63+ basal stem cell populations are 
either N2ICD+ (the active Notch2 intracellular domain) cells that differentiate into 
mature secretory cells, or c-myb+ cells that differentiate into ciliated cells (Fig. 1C) 
[26]. This specific segregation of progenitor cells was not found in homeostatic 
epithelium, which indicates that post-injury mechanisms may lead to different 
subsets of progenitor cells compared to the homeostatic epithelium [26]. A new study
shows Trp73 as a regulator of ciliated cell differentiation, which expression was 
observed in terminally differentiated ciliated cells as well as in Trp63+ basal 
cells. This indicates a direct transition from basal cell to ciliated cell as well as a
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segregation of epithelial cell fate at the basal cell level [27]. The role for Trp73 in 
response to damage and the trigger that is responsible for a Trp73+ basal cell to 
initiate ciliated cell differentiation is not yet studied . This would be essential in 
understanding the role of Trp73 in the Trp63+ basal cell population.
Clusters of Trp63+/Krt5+ cells, called distal alveolar stem cells (DASCs), are present 
in the distal airways after H1N1 influenza virus infection and have the capacity to 
replace injured alveolar cells (Fig. 2B) [28, 29]. Despite sharing similarity in markers, 
the tracheal basal stem cells (TBSCs) and DASCs show different fates in culture 
and in vivo transplantation. The TBSCs give rise to more proximal epithelium both 
in culture and in vivo, while the DASCs can form alveolar spheres in vitro and give 
rise to alveolar cells and secretory cells in vivo [29]. Krt5 lineage tracing studies 
concluded that these cells were not present before infection and were generated 
as a response to injury [29]. In addition to this finding, Vaughan and colleagues 
proposed a lineage negative epithelial precursor (LNEP) cell expressing Trp63+ 
and Krt5+ that helps to regenerate the alveoli after bleomycin injury. Transcriptional 
profiling of these cells indicate a very heterogeneous population suggesting that 
different cell types are present in the Trp63+/Krt5+ population [30]. Moreover, active 
Notch signaling was required to activate Trp63+/Krt5+ expression in LNEPs and 
active Notch prevents the further differentiation into AT-II cells [31]. This suggests 
that the hyperactive Notch signaling observed in lung diseases possibly contributes 
to failure of regeneration. In conclusion, basal cells can function as tissue-specific 
stem cells of the airway epithelium, but the heterogeneity in the population of basal 
cells is not yet completely understood. Since the identification of different subsets 
of basal cells is studied using lineage-tracing studies in mice, validation of these 
subsets of basal cells in human lung is of importance. Differences in progenitor 
populations are found in homeostatic epithelium compared to damaged epithelium. 
This suggests that in response to injury, molecular mechanisms are triggered that 
lead to the appearance of different subsets of epithelial progenitor cells, perhaps 
derived from one general homeostatic basal cell. Currently, signaling pathways are 
being identified that influence the expansion of basal cells and differentiation into 
specific cell types, but the precise underlying molecular mechanisms still need to 
be identified (Table 1). Furthermore, it is increasingly recognized that basal cells not 
only contribute to tissue repair, but are also a target for respiratory pathogens and 
contribute to host defense against infection [32]. Further studies, including those 
aimed at identifying subsets of basal cells that display these properties, are needed 
to better understand the link between this immune basal cell response and repair of 
the epithelium.
Other epithelial progenitor cells 
Basal cells are not the only identified multipotent cells in the lung (Table 2). Variant
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club cells, a subset of secretory cells that are positive for Secretoglobin family 1a 
member 1 (Scgb1a1) and negative for Cyp2f2, have been shown to self-renew 
and to differentiate into Cyp2f2+ secretory cells after naphthalene injury [3, 38, 
39]. Interestingly, another subset of Scgb1a1+ cells co-expressing the AT-II marker 
Surfactant protein C (Sftpc) was shown to differentiate into bronchiolar and alveolar 
lineages in vitro. These cells were called broncho-alveolar stem cells (BASCs) and 
are located at the broncho-alveolar duct junction (BADJ) (Fig. 2B) [40]. However, 
conflicting results are reported based on lineage tracing of Scgb1a1+ cells after 
lung injury. Scgb1a1+ cells differentiate into alveolar epithelial cells after influenza 
and bleomycin-induced injury, but not after hyperoxia-induced alveolar injury  [39, 
41]. This contradiction could result from different subsets of cells being labeled 
by the Scgb1a1-driven Cre driver, or from the activation of different pathways 
by hyperoxia and bleomycin. Cell-specific lineage tracing tools are required 
to give more clarity about the potential of BASCs and the variant club cells. 
Different alveolar progenitors and associating markers have been identified 
in response to lung injury and are summarized in Fig. 2B. AT-II cells expressing 
Sftpc are capable of self-renewal and a small fraction of mature type II cells can 
differentiate into AT-I cells in homeostasis and after injury [42, 43]. Besides the 
progenitor potential of AT-II cells, another progenitor subpopulation for alveolar 
epithelial cells has been identified. These cells co-express ɑ6 and ɑ4 integrins, but 
lack expression of Scgb1a1 or Sftpc. They respond to lung injury and can differentiate 
into AT-II cells and club cells. These cells reside in the alveoli as well as in the 
BADJ and their differentiation potential in vivo is most likely restricted by their niches 
[44]. Furthermore, a distinct population of Sca1+/Sftpc+ AT-II cells appeared at the 
onset of repair after infection of the lung by Pseudomonas aeruginosa intratracheal
Table 1 Overview Basal-like Stem Cell Populations
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Table 2 Other Potential Epithelial Stem cells
PLASTICITY OF THE LUNG
Further complexity and challenges in lung regeneration are generated by the 
plasticity of differentiated cells (Table 3). Independent studies have pointed at the 
potential of Scgb1a1+ secretory cells to dedifferentiate into Trp63+/Krt5+ basal 
cells upon depletion of the basal cell lineage or after damage of the lung epithelium 
[14, 49]. These dedifferentiated basal cells have the full capacity to redifferentiate 
into ciliated or secretory cells (Fig. 1C). The Hippo pathway and its down-stream 
effector Yap are required for the dedifferentiation of secretory cells [33]. Moreover, 
Yap has been shown to regulate stem cell proliferation and differentiation during 
normal epithelial homeostasis and regeneration upon injury in the adult lung [33, 50]. 
Further research showed that the nuclear-cytoplasmic distribution of Yap is important 
in the differentiation of adult lung epithelium and during development [16, 51]. Thus,
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instillation [45, 46]. Most of these cells were negative for ɑ4 integrin, Trp63 and 
Scgb1a1, separating them from respectively other distal progenitor cells and BASCs 
[28, 40, 44, 46]. Lineage tracing experiments showed that Sca1+ AT-II cells may 
arise from Sftpc+/Scgb1a1- cell and further differentiate into AT-I cell (Fig. 2B). This 
conversion of Sca1+ AT-II cells to AT-I cells depends on an active Wnt/β-catenin 
pathway [47]. Taken together, several populations are being marked as progenitor 
cells and the activity of subsets of progenitor populations seems to depend on their 
niches and kind of epithelial damage. The current challenge is to elucidate whether 
the different progenitor cells are indeed different cells, or if these cells are variants 
of a single precursor cell that are induced by different damaging agents. Single-cell 
RNA sequencing of the developing distal lung epithelium has helped in defining more 
precisely the different types of (progenitor) cells in the distal region of the developing 
lung [12]. A similar approach during regeneration of the proximal and distal lung 
epithelium might provide additional clues on the heterogeneity of epithelial cells 
upon repair.
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Fig. 2. Regeneration of distal and alveolar 
airway epithelium after injury. (A) The small 
airways lack basal cells and consist of cuboidal 
epithelium, containing secretory and ciliated 
cells, as well as clusters of neuroendocrine 
cells. The cuboidal epithelium passes into a 
broncho-alveolar duct junction which is the 
niche of broncho-alveolar stem cells. The 
alveolar epithelium consists of alveolar type 
I, type II cells and alveolar progenitor cells. 
(B) Variant club cells (Cyp2f2-) are a variant 
of secretory cells that survive naphtalene 
injury and give rise to cyp2f2+ club cells. 
Lineage tracing of Cgrp+ cells showed that 
after depletion of club cells by naphtalene 
injury neuroendocrine cells contribute to the 
regeneration of these cells. At the broncho-
alveolar duct junction, broncho-alveolar stem 
cells were isolated and shown to differentiate 
into bronchiolar and alveolar lineages in 
culture (dashed lines). Scgb1a1+ cells have 
the potential to form alveolar type I and type 
II cells after bleomycin injury, but not after 
hyperoxia-induced injury (dashed line). AT-II 
cells can self-renew and differentiate to AT-I 
cells. After pneumonectomy, a contribution 
of AT-I cells to regenerate AT-II cells was 
observed. An alveolar progenitor cell 
expressing α6-β4 integrins can regenerate 
AT-II cells after injury. Yet another cell type 
was identified expressing Sca1+ arising from 
AT-II cells and regenerating AT-I cells. Distal 
alveolar stem cells appear after severe injury 
and give rise to secretory and alveolar cells. 
Hippo signaling may be important in stimulating regeneration of the pseudostratified 
epithelium by controlling basal stem cell differentiation as well as luminal cell 
plasticity.
Differentiation of Foxj1+ ciliated cells to mucus-producing goblet cells was observed 
in human primary bronchial epithelial cell culture after exposure to IL-13, an important 
mediator in asthma [52]. Interestingly, this plasticity was not confirmed by a Foxj1+ 
lineage tracing study in mice using an ovalbumin-induced injury model [53]. Either 
the difference of damage to the epithelium, smoke versus ovalbumin, or the use of 
different species could account for the different outcomes.
Previous lineage tracing studies using lysozyme M as marker for mature AT-
II cells already demonstrated that AT-II cells can differentiate into AT-I cells [42]. 
More recently, a plasticity AT-I cells after pneumonectomy has been shown. To 
regenerate the alveoli, Hopx+ AT-I cells proliferate and differentiate into Sftpc+ AT-
II cells (Fig. 2B) [54]. The formation of AT-II cells from Hopx+ AT-I cells in organoid 
culture seems to be modulated by TGF-β signaling [54]. These results suggest a 
bi-directional transition between the two types of mature alveolar cells. However, 
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Table 3 Plasticity Of Differentiated Cells
REGENERATIVE MEDICINE
Drugs to induce lung regeneration
Different signaling pathways are involved in either maintaining a quiescent 
homeostatic or inducing a proliferating regenerating epithelium [3]. Signaling consists 
of cross-talk and feedback loops between epithelial cells but also between epithelial 
and mesenchymal cells. Such interplay between mesenchymal and epithelial cells 
is for example important in Hedgehog (Hh) signaling. In the adult lung, Hh signaling 
balances between stimulating proliferation and quiescence. In the homeostatic lung 
Hh signaling is active to maintain quiescence, however upon injury Hh signaling 
is inhibited to stimulate epithelial proliferation [58]. A shift in the balance can lead 
to failure of repair but can also play a role in promoting tumorigenesis [58, 59]. 
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after pneumonectomy the contribution of AT-I cells to regenerate AT-II cells is 
small (~10%). Vice versa, approximately 16% of regenerated AT-I cells are derived 
from Sftpc+ AT-II cells, indicating that other cell sources also contribute to re-
alveolarization [54]. Thus, strategies for regeneration of lung epithelium in disease, 
includes targeting of progenitor cell populations and activating the plasticity or fate 
of differentiated lung cells. Signaling cues to induce endogenous lung regeneration 
are starting to be identified and might be targets for disease therapies in the future. 
In line with initiating differentiation through signaling, it has been demonstrated that 
conversion of a specific cell type can be induced by changing the expression of a 
single protein. Ectopic expression of Sox2 in AT-II cells changed its alveolar cell type 
to a more proximal cell fate expressing Scgb1a1 and Trp63, even though the cells 
remained in the niche for distal cells [55]. A similar approach was used to show the 
plasticity of AT-I cells, where overexpression of Sox2 was sufficient to reprogram 
AT-I cells towards a proximal airway cell fate with expression of Trp63 [56]. The 
differentiation potential and plasticity of the lung epithelial cells as described in the 
above sections are illustrated in Figs. 1 and 2 to show the complexity of the cells 
involved in regenerating the lung epithelium.
Several pathways involved in lung development and regeneration are relevant in 
lung disease, and drugs that either inhibit or induce these pathways could have a 
beneficial effect for patients. Recently, it was shown that deletion of Notch3 leads 
to an expansion of basal cells, a hallmark of smokers and individuals with chronic 
obstructive pulmonary disease (COPD) [16, 60, 61]. Interestingly, Notch3 down-
regulation was observed in smokers and in COPD lung, making it a potential target for 
controlling the balance between basal and luminal cells [16, 62] Candidate pathways 
for targeting in COPD include Hedgehog signaling, Notch signaling, the retinoic acid 
pathway and the transforming growth factor-β (TGF-β) pathway [63]. The TGF-β 
pathway, as well as bone morphogenetic proteins (BMPs), growth differentiation 
factors and activins are also linked to asthma and these pathways could be potential 
drug targeting candidates [64]. In COPD there is mucus hypersecretion, and there 
are several ongoing studies that examine the effect of already marketed drugs on 
the production and secretion of mucus in COPD models [65]. Recently, it was shown 
that interference of Notch signaling with specific antibodies against the ligands 
Jag1 and Jag2 results in an increase in ciliated cells at the expense of club cells 
[66]. Moreover, jagged inhibition also reversed goblet cell hyperplasia, which could 
potentially be important in COPD patients to reduce the mucus production and to 
increase clearance by the ciliated cells. Fibroblast growth factors (FGFs) also play a 
role in regeneration of several tissues including the lung [67]. FGF1 and FGF2 are 
thought to play a role in the protection of epithelial stem cells and lung maintenance, 
and are linked to pulmonary hypertension. FGF1 is also thought to play a role in 
idiopathic pulmonary fibrosis. FGF7 and FGF10 are involved in lung regeneration 
and several different injury models show that these FGFs are important for repair 
of the lung. Several recombinant FGFs (FGF1, FGF2) and truncated forms of FGFs 
(FGF7, FGF10) are already used in clinical applications, like angiogenic therapies, 
coronary heart disease and treatment of ulcers [67]. Although these therapies are 
not yet available for lung diseases, there may be some future perspectives, either in 
inducing or inhibiting pathways involved in disease or by activation of endogenous 
lung progenitor cells. 
STEM CELLS
Stem cells are functionally characterized by their undifferentiated state and their 
properties of self-renewal and pluripotency to become specialized cells. Because 
of these characteristics, they are appealing to be used for the regeneration of 
damaged tissue. A distinction can be made between embryonic stem cells (ESCs) 
and adult stem cells. ESCs are derived from the inner cell mass of the blastocyst 
and these cells have the ability to differentiate into ectodermal, mesodermal and 
endodermal cell types. Human ESCs could be useful to study early embryonic 
development, for cell replacement therapy, to study disease pathways, and for drug 
discovery, although ethical and therapeutic issues hamper the use of these cells. 
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Besides ESCs, several types of adult stem cells throughout the human body exist, 
like hematopoietic stem cells, intestinal stem cells, mammary stem cells, olfactory 
stem cells, mesenchymal stem cells, endothelial stem cells, and neural stem cells. 
Adult stem cells are also capable of self-renewal and may differentiate into several 
cell types, but their differentiation potential is more restricted [68-70]. As indicated, 
there is accumulating evidence that differentiated cells show more plasticity than 
previously thought. Moreover, the number of different progenitor cells in the lung is 
higher than previously expected, depending on the type of injury or disease.
Induced pluripotent stem cells 
In 2006, the group of Yamanaka introduced a method to generate cells with properties 
similar to ESCs [71]. These so-called induced pluripotent stem cells (iPSCs) are 
somatic cells that are reprogrammed into a multipotent stem cell-like stage using 
only four different factors: Oct4, Sox2, cMyc and Klf4 (Yamanaka factors) [70]. 
Culturing these cells under distinct conditions induces several specialized cell types. 
iPSCs can be used for numerous applications, like disease modeling, regenerative 
medicine, drug discovery, and toxicity studies [70, 72]. The lung is a very complex 
organ that consists of many different specialized cell types, which makes it challenging 
to generate human airway and alveolar epithelial cells from iPSCs. First, definitive 
endoderm should be derived from human iPSCs (hiPSCs), followed by generation 
of anterior foregut endoderm [73]. From this anterior endoderm, lung endoderm 
can be derived, which can subsequently be guided towards bronchial progenitor 
cells (Sox2+) or alveolar progenitor cells (Sox9+), and finally towards bronchial or 
alveolar epithelial faith [70]. Several studies have shown the differentiation of ESCs 
and iPSCs into AT-II cells [74-79]. Other groups have shown the differentiation of 
iPSCs into multiciliated cells [80], mature airway epithelium expressing functional 
CFTR protein [81], multipotent lung and airway progenitors [82], purified lung and 
thyroid progenitors [83], purified distal lung alveolar epithelium [84], lung and airway 
epithelial cells [85], and lung and airway progenitor cells [86]. An overview of these 
differentiation protocols is given by Ghaedi and co-workers, although optimization  is 
clearly required before these cells may be used in clinical applications [70].
iPSCs may be used for the generation of patient-specific disease models and (large 
scale) drug screening, as shown for example with cells derived from patients suffering 
from cystic fibrosis [87]. A more clinical use of iPSCs in lung disease therapy is not 
yet approved and more knowledge is necessary before this will be applicable[88].
Mesenchymal stem cells
Mesenchymal stem/stromal cells (MSCs) are adult stem cells that have the potential 
to differentiate into cells derived from the mesoderm lineage. MSCs were first 
derived from bone marrow, but many other sources are reported, including umbilical
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cord blood, placenta, skin, liver and brain [89, 90]. MSCs refer to a heterogeneous 
population of cells, making it difficult to isolate them. Therefore, MSCs are defined by 
a number of criteria based on the expression of specific cell surface antigens and their 
functionality. Cells should express CD75, CD90 and CD105, but not CD34, CD45, 
HLA-DR, CD11b, CD19 and CD14. MSCs should be capable to differentiate into 
chondrocytes, osteoblasts and adipocytes, and should adhere to plastic for stable 
cell culture [68, 89-91]. Recent studies have shown that MSCs may differentiate in 
other cell types, including lung cells, although this is still controversial [92, 93]. It has 
been reported that MSCs can also be isolated from the lung. Martin et al. reported 
the isolation of MSCs from tracheal aspirates of neonates and from adult broncho-
alveolar lavage [94]. More recently, Gong and co-workers isolated lung resident 
MSCs and showed that these cells have the potential to differentiate into AT-II cells 
[95]. MSCs derived from other sources than the lung can also be differentiated into 
alveolar epithelium. These alveolar cells were generated from MSCs derived from 
human umbilical cord blood by culturing them in lung-specific differentiation media 
[93].
There are many completed and ongoing clinical trials using MSCs for applications 
in the nervous system, heart, liver and kidney. In lung disease, therapies with MSCs 
could be useful in bronchopulmonary dysplasia (BPD), COPD, acute respiratory 
distress syndrome and idiopathic pulmonary fibrosis [68, 89, 91, 96, 97]. However, 
given the low percentage of engraftment of the instilled MSCs as demonstrated in 
animal models, it is very likely that the beneficial effects of MSC therapy are not 
due to the differentiation potential of MSCs itself, but rather due to paracrine and 
immunomodulatory effects [89, 98-100]. 
Endothelial progenitor cells 
There are two different subsets of endothelial progenitor cells (EPCs), 
proangiogenic hematopoietic cells and endothelial colony-forming cells (ECFCs)
[101]. Proangiogenic hematopoietic cells are derived from the bone marrow and 
are involved in vascular repair. It is thought that these cells circulate to injury 
sites and there facilitate formation of new vessels using paracrine mechanisms, 
but lack direct vessel-forming ability. ECFCs are rare circulating blood cells 
that have the potential to generate cells that express genes from the endothelial 
lineage. They also have the potential to form blood vessels in vivo [101]. There 
is increasing evidence that EPCs are involved in several lung diseases, including 
COPD, BPD and pulmonary hypertension. Several lung injury animal models have 
shown (partial) reversal of the induced phenotype by systemic administration of 
EPCs, including improvement of pulmonary function and repair of the alveolar and 
vascular structure of the lung [102-104]. These therapeutic effects could be caused 
by structural conditions of the cells, by paracrine effects or by a combination of
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both [88]. The interaction between the pulmonary vasculature and the airways is 
important for proper growth and regeneration of the lung (reviewed in [105]). This 
was recently supported by the identification of endothelial derived angiocrine signals 
promoting alveolar regeneration after pneumonectomy [106, 107]. The interactions 
between the vasculature and epithelial cells upon repair are still elusive, but the 
identification of signaling molecules, like stromal cell-derived factor-1 (SDF-1), may 
be important for potential therapies. Systemic administration of EPCs has shown to 
be beneficial in patients with primary pulmonary hypertension [108, 109].  Several 
pre-clinical and clinical trials are ongoing to test the potential of using EPCs in lung 
disease therapies [88]. 
Besides the stem cells mentioned in this section, there are also endogenous lung 
progenitor cells that were discussed in previous sections. All these different stem/
progenitor cells are potentially targets for therapeutic strategies. While MSCs and 
EPCs could be effective because of their paracrine effects, iPSCs could be useful 
in the development of lung mimics and tissue engineering. Pathways involved in 
differentiation of lung progenitor cells to other cell types and plasticity of these cells, 
could be induced or inhibited by medication to induce lung regeneration.
LUNG MIMICS
Most studies on cell biology and tissue regulation are based on 2D cell-culture 
models. Although these models are valuable to answer specific scientific questions, 
it is clear that these models have limitations and fail to reconstitute the in vivo cellular 
microenvironment. Therefore, 3D cell-culture models were developed, which mimic a 
more realistic tissue- and organ-specific micro-architecture, although some aspects, 
including tissue-tissue interfaces and a mechanically active microenvironment are 
still missing. However, these models are very useful in patient-specific disease 
models, drug-screening and as a source of cells for transplantation [110]. 
Air-liquid interface cultures
Air-liquid interface (ALI) cultures mimic a more realistic lung environment and make 
it possible for airway epithelial cells to proliferate and differentiate in vitro. Whitcutt 
et al. were the first to demonstrate mucociliary differentiation using ALI cultures 
[111]. Culturing human airway epithelial cells from patients, makes it possible to 
conduct patient-specific research and drug-screening, for example in cystic fibrosis 
and asthma [112, 113]. ALI cultures were also used to model the effects of smoke 
exposure on epithelial cells, which could be used to gain more insight in mechanisms 
involved in the pathogenesis of COPD [114, 115]. In 2015, a new computer-controlled 
ALI culture system was introduced in order to generate more stable and comparable 
cultures, which may be useful for large-scale toxicology studies [116]. 
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Organoids
The concept of stem cell-derived organoids has already been discovered in the 
1950’s [117]. Organoid models use the pluri- or multi-potent properties of stem cells 
to differentiate into specialized cell types and to self-organize into a 3D structure 
with organ- or tissue-specific morphogenetic and histological properties [118-120]. 
Overviews of tissues and diseases modeled with organoids have been topics of 
recent reviews [119-121]. These tissues include intestinal buds, liver bud derivatives 
and retinal derivatives. In the intestine, single Lgr5+ stem cells can be isolated 
and grow into intestinal organoids [122]. Generation of lung organoids from one 
single stem cell have not been reported yet, but several studies have reported the 
generation of lung organoids derived from human pluripotent stem cells (hPSCs), 
primary respiratory cells and cell lines (reviewed in [123]). These organoids include 
trachea/bronchospheres [15, 124-126], bronchiolar organoids [127], bronchioalveolar 
organoids [126, 127], alveolospheres [43, 126, 127], branching structures [128-
130], alveolar spheroids [131] and multi-lineage organoids [132]. In 2015, Dye et 
al. established a protocol to successfully generate lung organoids derived from 
hPSCs (embryonic and induced). hPSCs were first differentiated into anterior 
foregut spheroids, using ActivinA, BMP and TGF-β inhibitors. This anterior foregut 
endoderm was subsequently induced into a lung lineage by modulating FGF and 
Hedgehog signaling. In this way, the foregut spheroids gave rise to lung organoids. 
These organoids possess both proximal airway-like structures and immature alveolar 
airway-like structures and are globally similar to fetal human lung. These human lung 
organoids can be used to study lung development and regeneration [133]. Previously, 
tracheospheres were used to show the capacity of basal cells to self-renew and the 
potential to form secretory and ciliated cells [13]. Jain et al. used organoid cultures to 
show the potential of Hopx+ AT-I cells to form AT-II cells [54]. Furthermore, application 
of the Clustered Regularly Interspaced Short Palindromic Repeats/Crispr associated 
protein (CRISPR/Cas) system in organoid culture might be a method to identify 
important players in epithelial cell differentiation. Recently, this approach was used 
to identify the role of transcription factor Grhl2 in the differentiation of ciliated cells 
[24]. In the future, the loss or gain of function by manipulation of genes in culture, 
will lead to more insight in potential stem cell populations in the lung. Organoids are 
very useful to answer specific questions about lung development and regeneration, 
but so far they are not exposed to air, resulting in incomplete differentiation of adult 
airway cells. Furthermore, it does not allow to expose organoids to air pollutants 
such as toxic gasses and micro- or nanoparticles, making it impossible to use them 
to study the effects of air pollutants on the airway epithelium.
Lung-on-a-Chip
Organs-on-chips refer to bioengineered devices that mimic tissue properties and 
functions in a well-controlled environment [118]. Additionally, there are also (acellular) 
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lung-mimicking microfluidic devices not specifically to study lung biology, but as 
respiratory assist devices or oxygenators [134]. Over the past decade, several micro-
engineered organ models 
have been developed to 
study liver, kidney, intestine, 
and heart, among others 
[135]. The first lung-on-
a-chip was introduced 
by Huh and co-workers, 
which mimicked the 
vascular-alveolar structure 
by using lung epithelial 
cells exposed to air on 
one side and pulmonary 
vascular endothelial cells 
exposed to flowing culture 
medium on the other side 
of a permeable synthetic membrane (Fig. 3, [136]). This model incorporated a 
microfluidics system and applied mechanical stress, and as such was capable of 
mimicking gas exchange. However, it  also has some limitations, since it uses a flat 
2D membrane, cell lines instead of primary cells, and lacks interstitial fibroblasts 
and alveolar macrophages [136-138]. In 2015, Stucki and colleagues reported a 
lung-on-a-chip with an integrated, bio-inspired respiration mechanism. This model 
used primary human pulmonary alveolar epithelial cells, which were co-cultured with 
endothelial cells and exposed to a 3D cyclic mechanical strain to mimic respiration 
[139]. The group of Blume developed a 3D model, consisting of an air- liquid interface 
culture of human primary airway epithelial cells in a microfluidic culture system. This 
system had a continuous exchange of fluids and mediators, thereby simulating the 
interstitial flow in the lung [140]. The power of using the lung-on-a-chip approach 
includes the possibility of connecting multiple devices, thereby creating a more 
realistic lung mimic by integrating microfluidics, stretch, curvature and primary cells. 
In addition to air-liquid-interfaces and mimicking stretch during in- and exhalation, 
the microfluidic approach allows to apply pressure and shear flow profiles both in 
alveoli and attached blood capillaries. Compartmentalized microfluidic systems 
make bioartificial/-engineered lung tissues also amenable for higher-throughput 
screening of the influence/impact of concentrations and mixtures of soluble factors in 
the blood/medium compartment, and of gases and particles in the air compartment.
TISSUE ENGINEERING
Although the above described systems are rapidly evolving, a huge hurdle is the 
generation of whole tissues and organs. There are three important demands to 
Fig. 3. Example of a human breathing lung-on-a-chip microdevice. 
Lung-on-a-chip microfluidic device with compartmentalized microchannels 
to mimic a breathing lung (From Huh et al., “Reconstituting organ-level lung 
functions on a chip”, Science 2010; 328:1662-8. Reprinted with permission 
from the AAAS [106]).See original reference for detailed description of the 
figure. In brief, (A) indicates the creation of mechanical breathing movements 
causing mechanical stretch of the membrane, (B) shows the physiology 
of the normal breathing human lung, (C) and (D) show the assembly and 
etching of the microdevice, and (E) visualizes the actual size of the device.
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successfully create tissues and organs: the source of cells, the type of scaffold, 
and the composition of the extracellular matrix (ECM). An appropriate mixture of 
cells should be used for the recapitulation of cell-cell interactions [141]. Appropriate 
scaffolds are necessary to obtain a 3D structure and can be either synthetic or 
biological, and biodegradable or non-biodegradable. In addition to the template 
three-dimensional structure, there is mechanical support and tissue instruction 
by engineered mechanical (e.g., through material or geometry-related matrix 
elasticity or stiffness), geometrical/topographical (e.g. through surface roughness 
or designed micro- or nanotextures) or (bio)chemical cues (e.g. RGD-adhesion 
moieties). An advantage of biodegradable scaffolds is that these are absorbed by 
the body. However, in the case of synthetic biodegradable scaffolds this may result 
in acidic degradation products causing inflammation in the surrounding tissue, e.g. 
when aliphatic polyesters like polylactic acid are used [142]. Compared to synthetic 
scaffolds, biological scaffolds are more similar to the tissue or organ that they should 
substitute, although biological scaffolds may lack sufficient mechanical properties 
[143]. Different types of biological scaffolds can be used like collagen, Matrigel® and 
decellularized organs [143]. Decellularization of organs has to be done in a proper 
way to as much as possible preserve all components of the extracellular space/
extracellular matrix components and their instructive properties. Several chemical, 
physical and enzymatical methods have been described to achieve this [68]. After 
decellularization, a process that does affect the extracellular matrix, the scaffold 
can be recellularized. Cells from different sources, as previously described, can be 
used for this purpose: embryonic, fetal or adult stem cells, autologous cells from the 
patient or iPSCs [68]. It is also possible to use allogeneic cells, e.g. in the case of 
transplantation of islets of Langerhans. There is also need for cells that are  involved 
in vascularization and innervation, and cells with supportive, structural and barrier 
functions. Using autologous cells would be ideal to prevent rejection of the tissue-
engineered organ in the patient, but could cause difficulties in the case of genetic or 
metabolic disorders [141]. Successful generation of tissue-engineered autologous 
bladders [144] and bio-engineered skin substitutes [145] have been reported as well 
as successful 3D bioprinting of several tissues and organs including multilayered 
skin, vascular grafts, heart tissue and tracheal splints [141, 146]. The structure 
and composition of the ECM should resemble that of embryonic organogenesis. 
It has been demonstrated that ECM signals are important to form pulmonary 
tissue structures in vitro [147]. Other signals, like cell-cell interactions, are also of 
importance to mimic the micro-environment of the organ [118, 148].
Tracheal bioengineering
In patients with a tracheal defect of 50% of total length in adults or 30% in children, 
artificial tracheal grafting is required [149]. Several approaches for tracheal epithelial 
differentiation have been tested, including co-culturing of tracheal epithelial cells with 
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fibroblasts or adipose-derived stem cells [150-152] and cell sheet engineering with 
tracheal epithelial cells [153, 154]. In spite of the controversies and success rate, 
Macchiarini et al. were the first group that transplanted a tissue-engineered airway 
[155]. The group of Steinke produced a bioartificial airway tissue using autologous 
primary cells to re-endothelialize and reseed a biological vascularized scaffold. 
After transplantation they observed complete airway healing and no evidence of 
tissue dedifferentiation [156]. Park and co-workers showed that human turbinated 
mesenchymal stromal cells cultured as intact sheets were able to differentiate into 
tracheal epithelium. These sheets were transplanted onto artificial grafts and tested 
in a rabbit model. After one month, regeneration of functional tracheal epithelium 
was observed [149]. Still, considerable problems are observed using tracheal grafts 
including failure to integrate and the formation of cartilaginous tissue [4, 68].
Vascular bioengineering
Interactions between epithelium, mesenchyme and endothelium are necessary 
for proper lung development and regeneration. Blood vessels secrete angiocrine 
factors that are involved in these processes including KLEIP, HIF-2α, VEGF, BMP-
4, FGF, MMP14, EET and TSP-1. Angiogenesis, the process where vessels are 
formed from a pre-existing network, is important for adult vascular homeostasis, 
regeneration and adaption. Angiocrine signaling is necessary for this process [105]. 
The important role of the vasculature is also recognized in tissue engineering. Ren 
et al. attempted to generate transplantable rat lung grafts by seeding epithelial and 
endothelial cells into the airway and vascular compartments of a decellularized 
lung scaffold from the rat. The major problem was poor vascular performance, 
causing incomplete endothelial coverage of the scaffold vessels. They optimized 
their protocol by co-seeding endothelial and perivascular cells which resulted in an 
endothelial coverage of 75% [157]. Even during decellularization of lung scaffolds, 
vascularization is important to preserve the integrity of the scaffold [158]. Orlova 
and co-workers showed that it is possible to generate endothelial cells and pericytes 
from human PSCs. This could provide a source of patient-specific vascular cells 
used in vascular bioengineering[159].
Whole lung bioengineering
Bioengineering of the whole lung is more complex than tracheal bioengineering 
due to the complexity of the lung. Lungs that are not suitable for transplantation 
can be decellularized and the scaffold can subsequently be used for seeding 
cells to regenerate the lung. It is still unknown which cell source is most suitable 
to repopulate the decellularized lung: MSCs, lung resident cells or a combination 
of both. Recently, it was shown that lung epithelial stem cells require co-culture 
with stromal cells to proliferate and differentiate. Fibroblasts have shown the 
highest efficiency in this support, and also the tissue origin of these cells gives 
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varying patterns of support. Also, the use of FGFs and LIF-, ALK5- and ROCK-
inhibitors activates proliferation and differentiation of quiescent lung stem cells [126]. 
Several methods were developed to decellularize lungs of rats, pigs, non-human 
primates and humans and to subsequently recellularize these scaffolds [160-166]. 
An overview of the currently available respiratory tract models, including the used 
cell sources and scaffolds, is reviewed by Nichols et al. [167]. 
CONCLUDING REMARKS
Knowledge about potential stem cells in the lung has markedly increased through 
various recent developments. One of the challenges will be to merge all the data 
from different species and obtained with various techniques into a simplified model 
of lung stem cells and their role in the normal and diseased lung.  Furthermore, a 
comprehensive view of all the (un)differentiated cells is still missing, because our 
repertoire of cell specific markers is still inadequate to identify the various cell types. 
One concern is that the use of different markers in individual studies might lead to 
the misconception that several subpopulations of progenitor cells exist, whereas 
there may possibly be only a few. In the future, the increase of cell-specific markers 
combined with single-cell lineage tracing should improve the definition of different 
(stem) cell populations in the lung. Additionally, a universal and unambiguous 
biological read out system to test the quality and purity of lung stem cells is also 
unavailable. So far, different systems, such as ALI cultures, organoids and explants, 
are successfully employed to fill this gap, but this makes it cumbersome to compare 
the various studies. Together with ESCs, iPSCs, MSCs and EPCs,  local lung stem 
or progenitor cells could be used for diverse clinical applications in the field of 
regenerative medicine. Current approaches to direct differentiation of stem cells, 
like iPSCs and MSCs, do generate lung-specific cells, but the specific lineages and 
the percentages of differentiated cells vary substantially. Therefore, optimization, 
improvement and expansion of the existing protocols is mandatory before clinical 
applications are possible. The manipulation of stem cells, like iPSCs, is required 
and useful for the development of lung mimics, for tissue engineering and for the 
generation of complete lung tissue. For tissue engineering applications, current 
scaffolds need to be improved or alternative suitable scaffolds need to be developed, 
which can be of synthetic and/or biological origin, and should contain appropriate 
ECM signals. Alternatively to bio-engineered lungs, specific pathways involved in 
differentiation of lung progenitor cells and plasticity of these cells may be targeted 
by novel compounds to induce their contribution to lung regeneration. Collectively, 
significant progress will be made through the interaction between very distinct 
scientific disciplines, such as developmental biology, biomedical engineering, and 
physics. These new and rapid developments in lung repair and regeneration offers a 
promising perspective for future patients with irreversible lung injury.
1.2
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ABSTRACT
Air-liquid interface (ALI) cultures of mouse tracheal epithelial cells (MTEC) are a 
well-established model to study airway epithelial cells, but current methods require 
large numbers of animals which is unwanted in view of the 3R principle and 
introduces variation. Moreover, stringent breeding schemes are frequently needed 
to generate sufficient numbers of genetically modified animals. Current protocols 
do not incorporate expansion of MTEC, and therefore we developed a protocol to 
expand MTEC while maintaining their differentiation capacity. MTEC were isolated 
and expanded using the ROCK inhibitor Y-27632 in presence or absence of the 
γ-secretase inhibitor DAPT, a Notch pathway inhibitor. Whereas MTEC proliferated 
without DAPT, growth rate and cell morphology improved in presence of DAPT. ALI-
induced differentiation of expanded MTEC resulted in an altered capacity of basal 
cells to differentiate into ciliated cells, whereas IL-13-induced goblet cell differentiation 
remained unaffected. Ciliated cell differentiation improved by prolonging the ALI 
differentiation or by adding DAPT, suggesting that basal cells retain their ability 
to differentiate. This technique using expansion of MTEC and subsequent ALI 
differentiation drastically reduces animal numbers and costs for in vitro experiments, 
and will reduce biological variation. Additionally, we provide novel insights in the 
dynamics of basal cell populations in vitro.
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INTRODUCTION
Airway epithelial cells play a pivotal role in protecting the lung by acting both as a 
mechanical and an immunological barrier. The epithelial cells of the upper respiratory 
tract form a pseudostratified epithelial layer consisting of several epithelial cell 
types that constitute an efficient host defense system that employs a variety of 
mechanisms, including its ability to clear inhaled particles and pathogens from the 
lung using mucociliary clearance. Efficient mucociliary clearance depends on a 
proper balance between basal, ciliated and secretory cells. The relative distribution 
of these cell types in the epithelial layer varies depending on the anatomic location 
within the conducting airways. Altered composition of these epithelial cell types 
has been implied in several chronic lung diseases, including asthma and chronic 
obstructive pulmonary disorder (COPD) [1-3].
Air-liquid interface (ALI) cultures of human primary airway epithelial cells (AEC) 
are a well-established in vitro model to investigate the role of airway epithelial cells 
in chronic lung diseases [4,5]. Primary AEC are isolated from bronchial biopsies, 
brushes or resected lung tissue, and can either be cultured directly onto transwell 
inserts or the cells can first be expanded in vitro for subsequent experimental use. 
AEC freshly isolated from lung tissue consist of multiple cell types, but during in vitro 
culture under submerged conditions the main population that will expand is the basal 
cells, the epithelial progenitor population [6,7]. Following in vitro expansion, primary 
AEC can be cultured on transwell inserts to establish ALI cultures. To this end, once 
the cultures have reached full confluence the apical medium is removed to induce an 
ALI that allows AEC to differentiate into a pseudostratified epithelial layer containing 
basal, ciliated and secretory cells [8]. Culturing primary airway epithelial cells at 
ALI provides a platform to investigate not only fully differentiated epithelial layers, 
but also the mechanisms of differentiation following airway epithelium damage and 
the dynamic processes of repair after injury [5]. Importantly, ALI cultures allow us to 
study the effect of airborne exposures on airway epithelial cells, e.g. whole cigarette 
smoke exposure [9].
In addition to primary human AEC, various research groups are using cultures of 
mouse tracheal epithelial cells (MTEC) [7]. These offer the opportunity to closely 
link in vitro and in vivo experiments, and make use of the large variety of transgenic 
mouse lines available. However, it is difficult to maintain MTEC in a proliferative 
state after isolation, and therefore MTEC are cultured directly onto transwell inserts 
without prior in vitro expansion. As a result, large animal numbers are needed to 
obtain adequate cell numbers for in vitro experiments. Therefore, novel methods 
are required to subculture MTEC in order to achieve a drastic reduction in animal 
numbers needed for experiments.
Expanding the progenitor cell population is essential to subculture MTEC. Basal 
epithelial cells are considered as the progenitor cell type for the maintenance of a
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pseudostratified airway epithelium of the upper respiratory tract [6]. The mechanisms 
that control progenitor cell renewal and differentiation to maintain the airway 
epithelium are still being uncovered, mostly owing to the complex cell-cell interactions 
and subsequent signaling involved in the decision making towards a specific cell 
fate. Notch signaling has been implied in the regulation of basal cell self-renewal and 
differentiation towards the specialized cell types of the epithelial layer. Importantly, 
inhibition of Notch signaling has been shown to allow expansion of the basal cell 
population [10-12].
To investigate the possibility of expanding MTEC while retaining the ability to 
differentiate, we have developed an alternative culture method that will lead to a 
drastic reduction in animal numbers needed for in vitro experiments. Moreover, 
subculturing MTEC would allow for increased numbers of in vitro experiments 
without using additional difficult-to-breed transgenic mice. To this end, we have used 
a combination of Notch signaling inhibition together with adaptation of existing cell 
culture methods to explore the possibility of subculturing MTEC and subsequent ALI 
differentiation. Additionally, we also investigated the effect of passaging MTEC on the 
basal cell type population as these cells are essential for subsequent differentiation 
into a pseudostratified epithelial layer consisting of multiple epithelial cell types.
RESULTS
Serum free medium and the inhibition of Notch signaling enables basal cell 
expansion
Although the current methods of ALI culture represent the pseudostratified airway 
epithelium in vitro, a limitation of this technique is the relatively low number of cells 
obtained from a trachea. We first validated the existing culturing method of MTEC 
whereby isolated MTEC are cultured directly onto transwell inserts (Fig. S1). This 
culture method allowed us to plate approximately 4 to 5 transwell inserts (50,000 cells 
per insert) using two mice (±100,000 cells per trachea). Improving the expansion of 
MTEC will allow for multiple experiments to be performed with fewer mice. Ideally, 
following isolation from the trachea, cells can be expanded in culture for at least two 
passages to generate sufficient cells for multiple experiments (Fig. 1a). In previous 
studies, MTEC are isolated and plated on inserts in proliferation medium and upon 
reaching confluency, cultured at ALI in differentiation medium (Table S1) [13-14]. 
Following expansion in proliferation medium, MTEC showed a limited proliferation 
capacity, with the presence of swollen cells with enlarged vacuoles (Fig. 1b). We 
were unable to successfully passage MTEC grown in proliferation medium. Because 
we considered the possibility that proliferation medium may be deficient in factors 
preventing senescence, we switched to another medium. Keratinocyte Serum Free 
medium supplemented with epithelial growth factor (EGF), Bovine pituitary extract 
(BPE) and isoproterenol (KSFM) allows for expansion of human airway epithelial
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2Fig. 1.  Expanding MTEC in KSFM 
expansion medium with Notch 
signaling inhibitor. (a) MTEC are 
expanded to passage 1 in KSFM 
expansion medium followed by 
passaging and culturing on transwell 
inserts. MTEC are grown to full 
confluence in MTEC proliferation 
medium, followed by air-liquid 
interface differentiation in MTEC 
differentiation medium. (b) Serial 
expansion of MTEC in different 
medium conditions. Epithelial cells 
are cultured in proliferation medium 
with ROCK inhibitor (Y27632), in 
KSFM medium with ROCK inhibitor 
or KSFM medium with ROCK inhibitor 
(Y27632) and γ-secretase inhibitor 
(DAPT). Phase-contrast images of the 
MTEC at various passages showing 
the morphology of the cells. Scale 
bar, 100µm.  (c) The graph represents 
the number of cells obtained after 
passaging when cultured in KSFM 
with ROCK inhibitor alone or in the 
presence of DAPT (mean ± SEM). * 
p < 0.05 by unpaired t-test (n=5). The 
table shows the number of 12-well 
inserts that can be obtained after each 
passage.
cells in vitro [15,16]. Additionally, adding a selective inhibitor of Rho-associated, 
coiled-coil containing protein kinase (ROCK), Y-27632, to the culture medium has 
been shown to increase proliferation of airway epithelial cells [17]. Growing MTEC 
in KSFM with Y-27632 indeed resulted in improved cellular expansion, survival and 
morphology (Fig. 1b). However, despite improved cell morphology and survival, the 
expansion rate was very slow and still a large number of enlarged cells were present. 
Notch signaling has been shown to play a pivotal role in preserving the basal cell 
population and in subsequent differentiation into specialized cell types. Furthermore, 
inhibition of Notch signaling has been shown to lead to an increased number of 
basal cells in mouse ALI cultures [10-12,18,19]. To evaluate whether inhibition of 
Notch signaling promotes the expansion of MTEC after isolation, we added DAPT, 
a γ-secretase inhibitor and indirect Notch signaling inhibitor, to the KSFM medium 
containing Y-27632. Growing MTEC in the presence of DAPT and Y-27632 in KSFM 
medium resulted in a marked increase in proliferation rate with a slightly better
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morphology compared to cells grown in absence of DAPT; these differences were 
already apparent after 5 days of culture of P0 cells, but even more after passaging 
whereby an increased number of transwell inserts could be obtained when DAPT 
was present during expansion (Fig. 1c). KSFM medium containing Y-27632 and 
DAPT will be further referred to as KSFM expansion medium.
Notably, expanding MTEC from two mice in KSFM expansion medium resulted 
in 42.5 million cells, sufficient for 85 transwell inserts when plated at a density of 
8 x 104 cells/cm2, which is in stark contrast to the 200,000 cells required for 4-5 
transwell inserts that are obtained if MTEC were isolated and cultured directly onto 
the transwell inserts. Also, no contaminating fibroblasts were observed during MTEC 
expansion. Taken together, we conclude that MTEC expansion is more efficient in 
the presence of the Notch signaling inhibitor DAPT than without.
Subcultured MTEC retain the ability to differentiate and develop a 
pseudostratified epithelial layer
Differentiation into a pseudostratified epithelial layer is essential when using MTEC 
cultures to mimic in vivo airway epithelium. To evaluate whether MTEC that were 
expanded in KSFM expansion medium retain the ability to form a pseudostratified 
epithelial layer in vitro, MTEC were isolated and cultured submerged in KSFM 
expansion medium. Subsequently, MTEC were cultured on inserts in MTEC 
proliferation medium until confluent, followed by differentiation at ALI in differentiation 
medium (Fig. 2a). Polarization of the pseudostratified epithelial layer in an apical and 
basal side was evaluated using keratin 8 (KRT8) and keratin 5 (KRT5), which mark 
the luminal and basal cell layer respectively. Cellular differentiation was analyzed 
by staining for specialized cell types, including ciliated cells using forkhead box 1 
(FOXJ1) and beta-tubulin IV (TUBB4B), club cells using secretoglobin, family 1A, 
member 1 (SCGB1A1) and basal cells using transformation-related protein 63 
(TRP63). Additionally, zona occludens 1 (ZO-1)-specific staining indicated epithelial 
tight junction formation, an important feature of epithelial cells to maintain a tight 
barrier function. After 8 days of differentiation at ALI we observed stratification of the 
epithelial cell layer, indicated by KRT5 expression in the basal cell layer and KRT8 
expression in the luminal cell layer, similar to ALI-MTEC cultures of P0 (Fig. 2b and 
S1). Although most of the cells were single positive for either KRT5 or KRT8, some 
cells were KRT5/KRT8 double positive, indicating the presence of basal luminal 
precursors which are cells transitioning from a basal to a luminal cell phenotype [20]. 
Expanded MTEC developed tight junctions when cultured at ALI (Fig. 2b). Additionally, 
ciliated and secretory cells were detected after 8 days of differentiation at ALI (Fig. 
2b). Epithelial polarization of expanded MTEC cultured at ALI was similar to the in 
vivo tracheal epithelium with TRP63 positive basal cells located at the basolateral 
side and the FOXJ1 positive ciliated cells at the apical side (Fig. 2b XZ plane, Fig. S1). 
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2Fig. 2. Expansion of MTEC in vitro leads to decreased ciliary and club cell differentiation. (a) Schematic 
representation of culture protocol. (b) Co-staining of different epithelial markers on MTEC passage 2 after 8 days 
of air liquid interface (ALI) culture. From left to right, inserts were stained with basal cell marker KRT5 and luminal 
marker KRT8, cilia cell TUBB4B with tight junction protein ZO-1, secretory club cell marker SCGB1A1 with cilia marker 
TUBB4B and the last panel shows TRP63 positive basal cells with ciliated cell marker FOXJ1. Nuclei are stained with 
DAPI (blue). Scale bar, 30 µm. (c) Resistance measurements of MTEC after different passages and 8 days of ALI 
(mean ± SEM). * p < 0.05 by one-way ANOVA (n=3). (d) Quantification of the percentage of FOXJ1 positive ciliated 
cells after 8 days of ALI comparing MTEC in passage (P) 0, 1 and 2 (mean ± SEM). * p < 0.05 by one-way ANOVA 
(n=3). (e) qRT-PCR analysis of Foxj1 in MTEC in passage (P) 0, 1 and 2 (mean± SEM). * p < 0.05 by one-way ANOVA 
(n=4). (f) Representative images and quantification of ciliated cells (FOXJ1) after 8 days or 21 days ALI and with or 
without the presence of DAPT during differentiation (mean ± SEM). * p < 0.05, *** P < 0.001 by two-way ANOVA (n=6). 
Scale bar, 30 µm.  
Taken together, these data show that expanded MTEC retain the ability to develop 
a pseudostratified epithelial layer, mimicking the in vivo pseudostratified epithelium. 
We next compared the epithelial differentiation potential between P0, P1 and 
P2 MTEC by assessing ciliated cells and barrier development after 8 days ALI 
differentiation. Whereas the P2 ALI-MTEC were able to develop ciliated cells, the 
percentage of FOXJ1 positive cells was lower compared to passages P0 and P1 after 
8 days of ALI differentiation (Figs 2d,e and S2). Barrier function was assessed using 
trans-epithelial resistance measurement, whereby the reduction in FOXJ1 positive
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cells was accompanied by a significant increase in barrier development between 
P0 and P2 ALI MTEC (Fig. 2c-e). In line with our immunofluorescence imaging, we 
observed a significant decrease in Foxj1 mRNA expression between P0 and P2 ALI 
MTEC (Fig. 2e). In addition to a decrease in FOXJ1 positive cells, we also observed 
a decrease in club cells as indicated by decrease in SCGB1A1 and SCGB3A2 
positive cells between P0 and P2 ALI MTEC as detected by immunofluorescence 
staining and mRNA expression (Fig. S2c and d).  Next we investigated whether the 
passaged MTEC could be treated in such a way that they develop ciliated cells in P2 
ALI MTEC. Previously, it was shown that the presence of DAPT during differentiation 
increases the development of ciliated cells [11,21]. To this end, we differentiated 
expanded MTEC in the presence of DAPT during ALI. Aside from the expected 
decrease of club cells [18], we found an increased number of FOXJ1 positive ciliated 
cells compared to MTEC that were differentiated at ALI without DAPT Moreover, 
increasing the duration of ALI differentiation also increased the number of FOXJ1 
positive cells (Fig. 2f). Overall, expanded MTEC cultured at ALI retain their ability 
to develop a pseudostratified epithelial layer. The differentiation of expanded MTEC 
appeared to be altered as indicated by a decrease in ciliated cells compared to 
P0. However, addition of DAPT during differentiation and increasing ALI duration 
increases the number of ciliated cells comparable to the numbers as observed in P0.
MTEC differentiation can be modulated using IL-13 to induce goblet cell 
metaplasia
Expanded MTEC cultured at ALI retained the ability to develop a pseudostratified 
epithelial layer. Next, we evaluated whether MTEC differentiation could be modulated 
using IL-13, which is important in the development of goblet cell metaplasia in 
mouse models of allergic airway inflammation [22,23]. We stained trachea of mice 
that were sensitized and exposed to house dust mite (HDM) allergen to induce 
allergic airways inflammation for the presence of goblet cells, and found these to be 
increased compared to placebo-treated mice (Fig. 3a). Previously, IL-13 has been 
shown to induce goblet cell metaplasia in vitro using ALI cultures of airway epithelial 
cells [15,24-26]. We exposed non-expanded (P0) and expanded (P1, P2) MTEC with 
DAPT to IL-13 during ALI culture and compared IL-13-induced MUC5AC expression 
patterns. Goblet cells are scarce in MTEC after 8 days of differentiation (Fig. 3c). 
However, we found that IL-13-exposed ALI MTEC cultures displayed increased 
numbers of goblet cells and there was no difference in the increase in goblet cells 
between P0 and P2 (Figs 3c and S3). Furthermore, IL-13 exposure resulted in a 
reduced number of ciliated cells in both ALI cultures with freshly isolated MTEC or 
with expanded MTEC (Fig. 3e). Finally, IL-13 decreases epithelial barrier function in 
vitro [27,28], which is in line with our results showing a similar reduction in barrier 
function following IL-13 exposure in expanded MTEC and isolated MTEC cultured 
directly onto inserts (Fig. 3d). Taken together our results indicate that expanding
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2Fig. 3. IL-13 exposure during MTEC differentiation induces goblet cells. (a) Hematoxylin and eosin on tracheal 
sections of control or house dust mite (HDM) treated mice. Immunofluorescence staining with Mucin 5AC (MUC5AC) 
shows the presence of goblet cells. MUC5AC expressing cells are indicated by the white arrows. Scale bar, 200 µm 
and 30 µm. (b) A schematic representation of the culture protocol. (c) Immunofluorescence staining of MUC5AC 
of MTEC passage 0 and 2 after 8 days of ALI culture with or without IL-13. Scale bar, 30 µM. Graph shows the 
percentage of MUC5AC expressing goblet cells in culture (mean ± SEM). * p < 0.05 by Student two-tailed t-test (n=3). 
(d) Resistance measurements after 8 days of ALI culture with or without IL-13 (5 ng/ml) treatment (mean ± SEM). * 
p < 0.05 by Student two-tailed t-test (n=3). Scale bar: 30 µm. (e) Immunofluorescence staining of FOXJ1 positive 
ciliated cells in a passage 0 (P0) and 2 (P2) after 8 days of ALI culture with or without IL-13 (5 ng/ml). Scale bar, 30 
µm. Graph show the percentage of FOXJ1 expressing ciliated cells in culture (mean ± SEM). * p < 0.05 by Student 
two-tailed t-test (n=3).  
MTEC in vitro does not affect their ability to induce a physiologic response to IL-13 
exposure, suggesting that this model could be an attractive alternative to evaluate 
new therapeutic compounds and their effects on airway epithelial cells in vitro. 
Intrinsic changes of the basal cell population result in decreased 
differentiation potential
Expanding MTEC before ALI differentiation resulted in reduced numbers of ciliated 
cells, suggesting an altered differentiation potential of the basal cell population. 
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The basal cell population consists of various subtypes with different functionality that 
can be identified by the presence of different basal cell markers [5-7]. To evaluate 
whether the altered differentiation potential could be explained by a change in 
basal cell composition at baseline, we first examined the TRP63 positive basal cell 
population at day 0 of ALI differentiation for P0, P1 and P2 (Fig. 4a). No significant 
differences were detected in the percentage of TRP63 positive basal cells between 
P0, P1 and P2 (Fig. 4b). This indicates that a difference in the number of TRP63 
positive basal cells is not the cause of an altered differentiation potential, suggesting 
that the identity of the TRP63 positive basal cell is changed. We therefore next 
evaluated the expression patterns of other previously published basal cell markers. 
KRT8 and KRT5 were already used to show stratification of the MTEC cultured at 
ALI (Fig. 2). As indicated, KRT5+KRT8 double positive cells mark a population of 
basal luminal precursor cells. Another marker used to distinguish basal cells is P75-
nerve growth factor receptor (NGFR), which is enriched in murine tracheal basal 
cells [6]. We observed no overt differences in KRT5, KRT8 and NGFR positive basal 
cells in P2 compared with P0 (Figs 4c,d,e and S4).
A subpopulation of keratin 14 (KRT14) positive basal cells is reported to be present 
in a small subset of basal cells, but is highly increased after injury and serves as 
a progenitor for ciliated and secretory cells [29,30]. We investigated the presence 
of KRT14 positive basal cells in P0 and P2 MTEC on inserts at day 0 of ALI. The 
KRT14 positive basal cell fraction showed a marked increase in P2 compared to 
P0 (Fig. 4e and f). Overall, our data suggests that Notch signaling is involved in the 
maintenance of the basal cell population and that expanding MTEC during Notch 
signaling inhibition increases the KRT14 positive basal cell fraction without affecting 
the other investigated basal cell populations.
DISCUSSION
Using a combination of Notch signaling and Rho-associated kinase (ROCK) 
inhibition and specialized media, we were able to subculture MTEC while preserving 
the mucociliary differentiation potential when cultured at ALI. This protocol provides 
a much more efficient way to culture MTEC, increasing the number of experiments 
that can be performed with two mouse tracheas, with approximately 42.5 million 
cells after passaging, which is in stark contrast to 200 000 cells if MTEC are plated 
on transwell inserts directly after isolation. Our culture method will contribute to a 
reduction in the number of animals used, in line with the 3R principle, and also has 
the potential to decrease technical and biological variation between experiments. 
Furthermore, a reduction in the number of animals needed is relevant when MTEC are 
isolated from difficult-to-breed mouse strains. To increase the efficient use of mouse 
trachea for MTEC culture, we have used KSFM medium to prevent outgrowthof 
fibroblasts (a common problem in MTEC cultures) supplemented with the ROCK
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2inhibitor Y-27632 and the γ-secretase inhibitor and indirect Notch signaling inhibitor 
DAPT. Additionally, our results indicate that expanding MTEC in vitro results in 
altered stemness of the basal cell population which is accompanied by a shift of 
a KRT14 negative basal cell population observed at P0 towards a KRT14 positive 
basal cell population at P2. Further investigation is required to evaluate contribution 
of the KRT14 positive basal cell population towards the altered stemness of the 
basal cell fraction.
Fig. 4. The population of TRP63 positive basal cells change during expansion. (a) Schematic representation of 
culture protocol. (b) Representative images of the number of TRP63 positive basal cells at ALI day 0. Scale bar, 30 
µM. Graph shows the percentage of TRP63 positive basal cells at day 0 of ALI culture in a passage 0 (P0), passage 1 
(P1) and passage 2 (P2) (mean ± SEM). One-way ANOVA (n=3). (c) Immunofluorescence of basal cell marker KRT5, 
and luminal cell maker KRT8 at day 0 of ALI. The overlay picture and the one-channel pictures are shown. The boxes 
indicate the area of which an enlarged image is presented. Scale bar: 30 µm. (d) Western blot analysis of KRT5 at day 
0 of ALI in a passage (P) 0 and 2. Beta-actin (ACTB) is used as loading control. * p < 0.05 by Student two-tailed t-test 
(n=7) (e) Immunofluorescence of basal cell marker, P75-nerve growth factor (NGFR) and basal cell maker keratin14 
(KRT14) at day 0 of ALI. Scale bar: 30 µm. (f) Western blot analysis of KRT14 at day 0 of ALI in a passage (P) 0 and 
2. Beta-actin (ACTB) is used as loading control. * p < 0.05 by Student two-tailed t-test (n=9)  
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MTEC have previously been shown to have the ability to grow in submerged 
culture. However, the ability of the MTEC to differentiate at ALI was not explored 
[31]. More recently, SMAD signaling inhibition was shown to promote airway basal 
stem cell expansion in vitro from multiple species with subsequent ALI differentiation 
[32]. Although this study contributed  significantly to the in vitro research field, the 
authors did not elaborate on cell culture techniques and growth media used. We 
used the SMAD signaling inhibitors described by Mou and colleagues in combination 
with KSFM medium, but observed that MTEC could not be expanded under these 
growth conditions (results not shown). In the present study, we have used KSFM to 
expand MTEC in vitro prior to culturing on transwell inserts. KSFM has previously 
been used successfully to expand primary human bronchial epithelial cells [15,16]. 
In addition, KSFM has the advantage of preventing outgrowth of fibroblasts, which 
is likely attributed to the low calcium levels, thus impairing fibroblast migration and 
proliferation [33-35]. An important advantage of the use of KSFM is therefore that 
it circumvents the need of culturing the isolated cell suspension for 4 to 5 hours 
on culture dishes to remove fibroblasts by adherence. This is important, since 
maintaining epithelial cells for several hours in suspension prevents them from 
adhering to a matrix, which may result in anoikis [36]. Our results indicate that MTEC 
do proliferate in KSFM, but the morphology, survival and expansion rates drastically 
improved when a ROCK inhibitor in combination with a Notch signaling inhibitor 
was used. Following expansion of MTEC in KSFM, we allowed MTEC to grow and 
differentiate on transwell inserts as previously described [14,17,37].
Expanding the progenitor basal cell population is essential for subculturing MTEC 
in vitro. ROCK inhibition is frequently used in embryonic stem cell cultures, induced 
pluripotent stem cells and some tissue-specific stem cell populations. More 
specifically, the ROCK inhibitor Y27632 has previously been shown to improve 
proliferation rates of human and mouse tracheal epithelial cells without affecting 
subsequent ALI differentiation [17]. Feeder layers or conditional medium from feeder 
layers has proven effective in expanding airway epithelial cells [38]. However, 
maintaining feeder layers adds significantly to the workload and exact mechanisms 
through which the feeder layers improve proliferation remain unknown. Therefore, 
using a defined culture medium without the need of feeder layers is preferred and is 
likely to result in increased consistence of the culture system.
A mechanism that has been suggested to underlie the ability of ROCK inhibitors to 
improve cell proliferation is the inhibition of downstream Notch signaling [39,40]. 
Whereas Y27632 improved MTEC proliferation rates in our experiments, cell 
morphology and survival suggested the presence of cell contact-induced impairment 
of cell proliferation. Cell-cell communication and related inhibition of proliferation has 
previously been attributed to Notch signaling [41]. Notch signaling has previously 
been shown to be involved in basal epithelial cell proliferation and differentiation
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2both in vitro and in vivo [10,11,18,21,41,41]. We therefore used DAPT, a γ-secretase 
inhibitor and indirect Notch signaling inhibitor, in combination with Y27632 in KSFM 
to expand MTEC in vitro. Our data shows that inhibiting Notch signaling is an effective 
way to expand the basal cell population. 
Differentiation of the basal cell population into a pseudostratified epithelial layer 
containing secretory and ciliated cells is an important feature of the airway epithelium. 
We have shown that MTEC expanded to passage 2 retain the ability to differentiate 
into a pseudostratified epithelial layer. To this end, we used KRT5 and KRT8 staining 
to discriminate between basal and luminal precursor populations. Some cells show 
the presence of both KRT5 and KRT8 which may mark basal cells differentiating 
towards a luminal precursor cell [11,20]. Furthermore, the pseudostratified epithelium 
of the trachea contains various cell types including basal, ciliated and secretory cells. 
Using FOXJ1 and TUBB4B staining for ciliated cells and SCGB1A1 and SCGB3A2 
staining for secretory cells in addition to qRT-PCR, we showed the presence of 
ciliated and club cells in expanded MTEC. However, the expanded MTEC had 
reduced numbers of ciliated and secretory cells present after 8 days of ALI, despite 
the unchanged KRT8 positive luminal fraction in P2 compared to P0.  This suggests 
that the cells may require more time or an additional trigger for efficient end-stage 
differentiation. This hypothesis is strengthened by the observed increase in ciliated 
cells by extending the duration of ALI. This was further increased by adding the 
Notch inhibitor DAPT during ALI, which is in line with previous studies showing that 
inhibition of Notch signaling may drive epithelial cells towards ciliated cells [21,43]. 
Collectively, these findings indicate that after expansion in culture, basal cells retain 
the ability to develop a pseudostratified epithelial layer following ALI differentiation, 
but with an altered differentiation capacity, likely resulting from altered stemness 
of the basal cell population. Additional triggers generated by extended culture and 
Notch inhibition, are required to achieve more efficient mucociliary differentiation. 
The ability to adapt to a changing environment to various stimuli is an important 
feature of airway epithelial cells. Furthermore, appropriate in vitro epithelial culture 
models should recapitulate the response to disease-specific stimuli observed in 
patients and/or animal models of disease. To this end, we used IL-13 exposure and 
assessment of subsequent goblet cell development of expanded MTEC cultured at 
ALI to mimic the in vivo allergic airways inflammation. IL-13 is a T helper 2 cytokine 
known to induce goblet cell metaplasia in vivo and in vitro [22,23,25,44,45]. IL-
13 exposure during differentiation induced MUC5AC positive goblet cells in both 
expanded MTEC and in freshly isolated MTEC that were cultured directly onto 
inserts. 
The presence of IL-13 during differentiation at the ALI resulted in an increased 
number of goblet cells, likely resulting from basal cells differentiating towards goblet 
cells rather than ciliated cells. Alternatively, the increased number of goblet cells may
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be resulting from IL-13 induced trans-differentiation of ciliated cells towards goblet 
cells, resulting in fewer ciliated cells [26,45,46]. Moreover, IL-13 induced a reduction 
in barrier function in both expanded MTEC and isolated MTEC that had been 
cultured directly onto transwell inserts, which is in line with previous publications 
showing that IL-13 reduces barrier function in vitro [27,28]. Overall, expanded MTEC 
showed a robust response following IL-13 exposure including decreased barrier 
function and the development of goblet cells, indicating that expanding MTEC in vitro 
using a Notch signaling inhibitor does not affect their ability to respond to IL-13. The 
observation that goblet cell differentiation induced by IL-13 exposure is similar in P0 
and P2, suggests that the basal cells retain the ability to differentiate into goblet cells.
Basal cells are the main progenitor cells of the conducting airways. They have 
the proficiency to self-renew and differentiate into various cell types found in a 
pseudostratified epithelial layer including ciliated and secretory cells. Various cellular 
markers have been described to distinguish basal cells in the airway epithelium. 
Furthermore, basal cells can be separated in various subsets depending on the 
combination of cellular markers present [5,7]. KRT5, TRP63 and NGFR are commonly 
used markers to delineate basal cell populations. In contrast, only a small fraction 
of basal cells is positive for KRT14 at baseline. Our results indicated that expansion 
significantly induced a KRT14 positive basal cell population in P2 compared to P0, 
whereas the other investigated basal cell populations remained unaltered between 
passages. Together these data suggest that expanding basal cells in vitro can 
alter the composition of the basal cell population, which may explain why we see 
a reduced number of ciliated cells in expanded MTEC compared to isolated MTEC 
cultured directly onto inserts. Whether this alteration of the basal cell population 
results from the KRT14 negative basal cell population turning KRT14 positive or 
that the KRT14 positive basal cell population has an increased capacity to expand 
in vitro compared to the KRT14 negative basal cell population remains to be further 
investigated. However, KRT14 positive basal cells are still able to differentiate in 
ciliated cells and goblet cells when exposed to additional triggers, respectively DAPT 
and IL-13, in a similar way as KRT14 negative basal cells. More research is needed 
to investigate the role of KRT14 positive basal cells and their ability to differentiate.
In conclusion, we developed a clearly defined culture method that allows ALI 
differentiation of MTEC into a pseudostratified epithelial layer following in vitro 
expansion. Expanding MTEC in vitro did result in decreased differentiation of basal 
cells to ciliated cells, likely resulting in part from an altered composition of the basal 
cell population as indicated by an increase in KRT14 positive basal cells. Despite the 
altered basal cell population, the Th2 cytokine IL-13 was still able to redirect epithelial 
differentiation towards a phenotype observed in allergic airways inflammation. 
Furthermore, this culture method may be useful to study repair following injury 
combined with in vitro lineage tracing if MTEC from transgenic animals are used. 
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2Also, this new culture method will contribute to a reduction in animals needed for 
experimentation, in line with the principles of the 3R’s (Replacement, Reduction and 
Refinement).
METHODS
Culture media and supplements
A detailed overview of all culture media and supplements can be found in supplemental 
table 1. “Ham´s F12” is defined as Ham´s F12 (Gibco, Bleiswijk, The Netherlands) 
supplemented with 100 U/ml penicillin and 100 µg/ml streptomycin (Lonza, Verviers, 
Belgium). “MTEC basic” medium is defined as DMEM/F12 (Gibco) supplemented 
with 100 U/ml penicillin, 100 µg/ml streptomycin and 0.03% (w/v) NaHCO3 (Gibco). 
“KSFM expansion medium” is defined as KSFM (Gibco) supplemented with 1% 
penicillin-streptomycin, 1 µM isoproterenol (Sigma-Aldrich, St. Louis, MO, USA), 
0.03 mg/ml bovine pituitary extract (Gibco), 25 ng/ml murine epidermal growth 
factor (Peprotech, Rocky Hill, NJ, USA) and 10 µM Y-27632 hydrochloride (Cayman 
Chemical, Ann Arbor, MI, USA). “MTEC proliferation medium” is defined as MTEC 
basic supplemented with 5% (v/v) Fetal Bovine Serum (FBS), 1.5 mM L-glutamine 
(Lonza), 1x (v/v) Insulin-Transferrin-Selenium (Gibco), 0.1 µg/ml cholera toxin 
(Sigma-Aldrich), 25 ng/ml murine epidermal growth factor, 0.03 mg/ml bovine pituitary 
extract, 0.05 µM retinoic acid (Sigma-Aldrich) and 10 µM Y-27632 hydrochloride. 
“MTEC differentiation medium” is defined as MTEC basic supplemented with 0.1% 
(w/v) bovine serum albumin (BSA) (Gibco), 1.5 mM L-glutamine, 1% (v/v) Insulin-
Transferrin-Selenium, 25 ng/ml cholera toxin, 5 ng/ml murine epidermal growth 
factor, 0.03 mg/ml bovine pituitary extract and 0.05 µM retinoic acid. Retinoic acid 
and Y-27632 hydrochloride stocks were prepared and stored at -80 °C and -20 °C 
respectively, and were supplemented fresh for cell culture usage and used within the 
same day. Culture media containing retinoic acid were protected from light.
Mouse tracheal epithelial cells (MTEC) isolation and culture
All animal experimental protocols were approved by the animal welfare committee 
of the veterinary authorities of the Leiden University Medical Center or the Erasmus 
Medical Center. Wild-type C57Bl/6 mice were used for isolating murine tracheas. 
MTEC were isolated as described previously [14]. After isolation, MTEC were 
resuspended in MTEC basic containing 10% FBS for direct culture on transwell 
inserts, or in KSFM for further passage and expansion of MTEC.
In experiments in which MTEC were grown on transwell inserts directly after isolation 
without passaging of the cells in KSFM expansion medium, the cells were first 
deprived of fibroblasts by incubating the cells on Primaria plates (Corning Costar, 
Cambridge, MA, USA) for 5 h at 37°C with 5% CO2. Non-adherent cells were collected 
and centrifuged at 390xg for 10 min at room temperature. Cells were resuspended in 
MTEC proliferation medium, plated at 8 x 104 cells/cm2 on transwell inserts (0.4 µm
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pore size; Corning Costar) and cultured submerged until confluent at 37°C with 5% 
CO2. MTEC proliferation medium was refreshed every two to three days.
For MTEC subculture experiments, trachea-derived cells were collected in KSFM 
expansion medium and plated in T75 flasks at 5 x 103 cells/cm2. The adherence 
step using Primaria plates to remove fibroblasts was omitted when using KSFM, 
since this medium is formulated by the provider to prevent fibroblast growth. KSFM 
expansion medium was supplemented with DAPT (Sigma-Aldrich), a Notch signaling 
inhibitor, according to the experimental design described in the results section. At 80 
– 90% confluence, MTEC were passaged using 0.25% (w/v) trypsin (Gibco) and 2.7 
mM EDTA (Sigma-Aldrich) in Cell Dissociation Solution Non-enzymatic 1x (Sigma-
Aldrich). MTEC were plated at 5 x 103 cells/cm2 in KSFM. Passage 1 or passage 2 
MTEC were used for further experiments. For culturing onto transwell inserts, cells 
were dissociated with Cell Dissociation Solution (Sigma-Aldrich) supplemented with 
0.25% trypsin and 2.7 mM EDTA at 37°C for 15 min, centrifuged at 390 g for 10 min 
at room temperature and resuspended in MTEC proliferation medium. MTEC were 
plated on transwell inserts at 8 x 104 cells/cm2 and cultured in MTEC proliferation 
medium until confluent at 37°C with 5% CO2. MTEC proliferation medium was 
refreshed every two to three days. A schematic overview of the expansion method 
followed is given in figure 1.
After MTEC cultured on transwell inserts had grown to full confluence, apical medium 
was removed to achieve air-liquid interface (ALI) culture conditions. After the start of 
culture at ALI, the apical surface was washed with warm PBS and the basal medium 
was refreshed using MTEC differentiation medium every two to three days.
For experimental exposures, ALI-MTEC were exposed to either 5 ng/ml murine IL-13 
(Peprotech) or 5 µM DAPT, added in the basolateral chamber of the transwell insert 
for the indicated duration. 
RNA extraction, cDNA synthesis and Quantitative RT-PCR analysis
Cells were collected in PBS from the insert using cell-scrapers on ice. After 
centrifugation at 4 °C, 5000rpm for 5 min, the cell pellet was lysed using TRIzolTM 
reagent (Life Technologies, Rockville, MD, USA). RNA extraction was performed 
according to the TRIzolTM Reagent protocol. RNA concentrations were measured 
using Nanodrop (Thermofisher Scientific). First strand cDNA synthesis was 
synthesized using MLV Reverse transcriptase (Sigma, M1302) with Oligo(dT) 
primers (self-designed: 23xT + 1A, 23xT + 1C and 23xT + 1G).   Quantitative RT-PCR 
analysis was performed with 0.5 µl of cDNA per reaction, Platinum Taq polymerase 
(Invitrogen, 18038042) and SybrGreen (Sigma, S9430). The primer combinations 
for the qRT-PCR are listed in supplemental table 3. Relative gene expression was 
calculated using the ∆∆CT method relative to GAPDH control.
Allergic airway inflammation in mice
To induce allergic airway inflammation in mice, 8 to 12 weeks old female C57BL/6 mice
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2were sensitized by intranasal instillation of 1 µg Dermatophagoides pteronyssinus 
extract (house dust mite extract (HDM)) in 50 µl PBS, followed by 5 daily intranasal 
challenges with 10 µg HDM in 50 µl PBS or PBS starting at 7 days after sensitization. 
Mice were sacrificed 2 days after the last challenge. Trachea were removed and fixed 
in 4% paraformaldehyde (PFA) (Sigma-Aldrich) and stained for confocal analysis as 
described below.
Immunofluorescence of ALI-MTEC culture
MTEC on inserts were rinsed with PBS followed by fixation with 4% (w/v) 
paraformaldehyde (PFA) for 10 min at room temperature. After fixation cells were 
washed 3 times with PBS/0.2% (v/v) Triton-X100 (Sigma-Aldrich) to remove residual 
mucus from the apical surface. Non-specific binding sites were blocked with 5% 
(v/v) donkey serum (EMD Millipore, Billerica, MA, USA), 1% (w/v) BSA and 0.2% 
(v/v) Triton-X100 in PBS for 30 min at room temperature, followed by incubation 
with primary antibodies in blocking buffer at 4°C overnight (Supplemental table 2). 
The next day, MTEC were washed three times with PBS/0.02% Triton X-100 and 
incubated for 2 h at room temperature with Alexa Fluor labeled secondary antibodies 
(Jackson ImmunoResearch, West Grove, PA, USA) in blocking buffer (Supplemental 
table 2). After three washing steps with PBS/0.02% (v/v) Triton-X100 and one 
washing step with PBS, the cells were mounted with Vectashield hardset containing 
DAPI (Vector Laboratories, Burlingame, CA, USA). Images were acquired using a 
Leica SP5 confocal microscope. Cell counting was performed using ImageJ and 10-
15 areas from each insert were analyzed for each replicate. 
Immunofluorescence of tracheal sections 
Mouse tracheas were fixed with 4% PFA overnight at 4°C, washed with PBS 
and embedded in paraffin for sectioning. Tracheas were sectioned (5 µm) and 
deparaffinized, rehydrated and subjected to antigen retrieval in Tris-EDTA (pH 9.0) 
at 600W for 15 min. After blocking with PBS plus 5% donkey serum and 0.05% 
Tween-20, sections were incubated with primary antibodies in blocking buffer 
overnight at 4°C (Supplemental table 2). The next day, sections were washed with 
PBS/0.05% Tween (3x, 5 min). Alexa Fluor labeled secondary antibodies were used 
in a 1:500 dilution in blocking buffer and sections were incubated for 2 h at room 
temperature. After incubation, sections were washed (3x, 5 min) with PBS/0.05% 
Tween-20 followed by one final wash with PBS only. Sections were mounted with 
Vectashield hardset containing DAPI (Vector Laboratories) and confocal images 
were obtained using a Leica SP5 confocal microscope.
Trans-epithelial electrical resistance (TEER)
TEER values were measured with an STX2 electrode (World Precision Instruments, 
Berlin, Germany) connected to a Millicell ERS voltohmmeter (World Precision 
Instruments). Prior to measurement, 700 µl prewarmed PBS was added apically to the 
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ALI-MTEC and incubated at room temperature for 10 min. Resistance measurements 
were corrected for the surface of the transwell inserts and expressed as Ohm * cm2.
Western blot analysis
Cells were washed twice with PBS, scraped of the insert in PBS and pelleted. 
Cells were lysed in Carin lysis buffer containing 20mM Tris-HCl pH 8.0, 137 mM 
NaCl, 10 mM EDTA, 10% glycerol and 1% NP-40 and incubated on ice for 15 min. 
Complete protease inhibitors (Roche) was freshly added each time to the lysis 
buffer. Samples were centrifuged for 5 min at 18,711 g in an Eppendorf5417R at 4°C. 
Pellets were discarded and supernatant was used for western blot analysis. Protein 
concentrations were determined by the Pierce® BCA Protein Assay Kit (Thermos 
scientific) and equal concentrations of protein were eluted in 4x SDS sample buffer 
and 50mM 1,4-dithiothreitol (DTT, sigma). Samples were boiled and loaded on a 
12% SDS-polyacrylamide gel and blotted onto a PVDF membrane (Immobilon®-P 
transfer membrane, Millipore). The blots were blocked for 1h in PBS containing 
0.05% Tween-20 and 3% BSA at room temperature, and probed overnight with 
primary antibodies at 4°C. Next day, membranes were washed three times with 
PBS containing 0.05% Tween-20 and incubated for 1 h with horseradish peroxidase 
(HRP)-conjugated secondary antibodies (DAKO) at a dilution of 1:10,000. Signal 
was detected with AmershamTM ECLTM Prime Western Blotting Detection Reagent 
(GE Healthcare). Blots were developed using the Amersham Typhoon imaging 
system (GE Healthcare). 
Statistical analysis
Data are represented as means with standard error of mean of measurements. Sta-
tistical differences between samples were assessed with a one way or two way 
analysis of variance (ANOVA) or unpaired t-test. Differences at P-values below 0.05 
are considered significant (* p<0.05). All statistical analyses were performed using 
Graphpad PRISM version 5.02.
Data availability statement
All data generated or analyzed during this study are included in this published article 
(and its Supplementary Information files).
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2SUPPLEMENTARY METHODS
Medium Component
Provider
(catalogue number)
Final concentration
KSFM expansion 
medium
KSFM Gibco (17005034)
Penicillin
Streptomycin
Lonza (DE17-602e)
100 U/ml
100 µg/ml
Murine EGF Peprotech (315-09) 0.025 µg/ml
Bovine Pituitary Extract Gibco (13028014) 0.03 mg/ml
Isoproterenol Sigma (I-6504) 1 µM
Y-27632 (add fresh) Cayman Chemical (10005583) 10 µM
DAPT (add fresh) Sigma (D5942) 5 µM
MTEC Basic (*)
DMEM/F12 Gibco (1133032)
Penicillin
Streptomycin Lonza (DE17-602e)
100 U/ml
100 µg/ml
NaHCO3 Gibco (25080094) 0.03% (w/v)
MTEC 
proliferation 
medium
MTEC basic (*)
L-Glutamine Gibco (25030081) 1.5 mM
Fetal Calf Serum HyClone (SH30071.03) 5%
ITS-G Gibco (41400045) 1x
Cholera Toxin Sigma (C8052-0.5mg) 0.1 µg/ml
Murine EGF Peprotech (315-09) 0.025 µg/ml
Bovine Pituitary Extract Gibco (13028014) 0.03 mg/ml
Y-27632 (add fresh) Cayman Chemical (10005583) 10 µM
Retinoic Acid Sigma (R2625-50mg) 0.05 µM
MTEC 
differentiation 
medium
MTEC basic (*)
L-Glutamine Gibco (25030081) 1.5 mM
Bovine Serum Albumin Gibco (15260037) 0.1% (w/v)
ITS-G Gibco (41400-045) 1x
Cholera Toxin Sigma (C8052-0.5mg) 0.025 µg/ml
Murine EGF Peprotech (315-09) 0.005 µg/ml
Bovine Pituitary Extract Gibco (13028-014) 0.03 mg/ml
Retinoic Acid Sigma (R2625-50mg) 0.05 µM
Suppl. Table 1: Overview of culture media and supplements
Primary Antibody Provider (Catalogue number) Dilution
Beta-Tubulin IV BioGenex, MU178-UC, Mouse monoclonal 1:100
SCGB1A1 (CCSP) From Dr. Barry Stripp, Goat polyclonal 1:5000
SCGB1A1 (CCSP, Uteroglobin) Abcam, ab40873, Rabbit polyclonal 1:200
UGRP1/SCGB3A2 R&D Systems, af3465, Goat polyclonal 1:500
FOXJ1 eBioscience, 14-9965, Mouse monoclonal 1:300
KRT5 Biologend, Poly19055, Rabbit polyclonal 1:500
KRT8 DSHB, TROMA-I, Rat monoclonal 1:100
MUC5AC Abcam, ab3649, Mouse monoclonal 1:500
TRP63 Santa Cruz, sc-8343, Rabbit polyclonal 1:50
Zona Occludens 1 Invitrogen, 61-7300, Rabbit polyclonal 1:100
KRT14 EMD Millipore, CBL197, Mouse monoclonal 1:100
NGFR Promega, Anti-Human P75 pAb, Rabbit polyclonal 1:200
Β-ACTIN Cell Signaling, 4967, Rabbit polyclonal 1:1000
Secondary Antibody
Alexa Fluor ®488, 594 Donkey anti Goat 
IgG
Jackson ImmunoResearch (111301), (112406)
1:500
Alexa Fluor ®488, 594 Donkey anti 
Mouse IgG
Jackson ImmunoResearch (112976), (110989)
1:500
Alexa Fluor ®488, 594 Donkey anti 
Rabbit IgG
Jackson ImmunoResearch (113254), (113078)
1:500
Alexa Fluor ®594 Donkey anti Rat IgG Jackson ImmunoResearch (127426) 1:500
Anti-mouse HRP conjugated DakoCytomation (P 0447) 1:10,000
Anti-rabbit HRP conjugated DakoCytomation (P 0448) 1:10,000
Suppl. Table 2: Antibody overview
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Suppl. Table 3: Primer overview
Primer Forward primer Reverse primer
Foxj1 5’-CAGACCCCACCTGGCAGAATTC-3’ 5’-AAAGGCAGGGTGGATGTGGACT-3’
Scgb1a1 5’-GCAGCTCAGCTTCTTCGGACA-3’ 5’-TCCTGGTCTCTTGTGGGAGGG -3’
Scgb3a2 5’-GTGGTTATTCTGCCACTGCCCTT-3’ 5’-TCGTCCACACACTTCTTCAGTCC-3’
Trp63 (∆NP63)1 5’-GGAAAACAATGCCCAGACTC-3’ 5’-GATGGAGAGAGGGCATCAAA-3’
Krt5 5’-TACCAGACCAAGTATGAGGAG-3’ 5’-TGGATCATTCGGTTCATCTCAG-3’
Krt8 5’-CTCATCAAGAAGGATGTGGAC-3’ 5’-GAGGAAGTTGATCTCGTCGG-3’
Krt14 5’-CGGCAAGAGTGAGATTTCTG-3’ 5’-AGGGATGCTTTCATGCTGAG-3’
Ngfr 5’-CGCTGACAACCTCATTCCTG-3’ 5’-GCTGTTCCATCTCTTGAAAGC-3’
Gapdh 5’-CCTGCCAAGTATGATGACAT-3’ 5’-GTCCTCAGTGTAGCCCAAG-3’
1. Zhao et al. Yap tunes airway epithelial size and architecture by regulating the identity, maintenance, and self-renewal 
of stem cells. Dev Cell 2014
Suppl. Fig. 1. MTEC ALI cultures recapitulate the in vivo pseudostratified airway epithelium. (a) Hematoxylin 
and eosin staining of a mouse tracheal sections and immunofluorescence co-staining on tracheal sections with basal 
cell marker KRT5 and luminal cell marker KRT8, cilia marker TUBB4B with tight junction protein ZO-1 (indicated by 
the arrows), secretory club cell marker SCGB1A1 with cilia marker TUBB4B and the last panel shows TRP63 positive 
basal cells with ciliated cell marker FOXJ1. Nuclei are stained with DAPI (blue). Scale bar, 200 µm and 30 µm. (b) 
Schematic representation of ALI culture. (c) Co-staining of the different epithelial markers on MTEC ALI culture. The 
arrow marks a basal luminal precursor cell that is both positive for KRT5 and KRT8. Orthogonal view shows a stratified 
epithelium. Nuclei are stained with DAPI (blue). Scale bar, 30 µm.
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Suppl. Fig. 2. Representative images of P1 on inserts. (a) Schematic representation of ALI culture. (b) Co-staining 
of different epithelial markers on MTEC passage 1 after 8 days of Air Liquid Interface (ALI) culture. From left to right, 
inserts were stained with KRT5 for the basal cell layer and differentiation marker KRT8, Ciliated cell marker FOXJ1 
with tight junction protein ZO-1, secretory cell marker SCGB1A1 with cilia marker TUBB4B and the last panel shows 
TRP63 positive basal cells with ciliated cells. Nuclei are stained with DAPI (blue). Scale bar, 30 µm. (c) Staining of 
SCGB1A1 an SCGB3A2 expressing secretory cells in MTEC passage (P) 0 and 2. Scale bar, 50 µm. (d) qRT-PCR of 
Scgb1a1 and Scgb3a2 mRNA in MTEC P0 and P2 at 8 days of ALI (mean± SEM). * p < 0.05 by one-way ANOVA (n=4).
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Suppl. Fig.3. IL-13 treatment stimulates the formation of goblet cells in vitro. (a) Schematic representation of 
culture protocol. (b) Staining of Mucin 5AC (MUC5AC) expressing goblet cells in MTEC (Passage 1, P1) after 8 days 
of ALI with or without IL-13 (5 ng/ml). Nuclei are stained with DAPI (blue). Scale bar: 30 µM. (c) Staining of FOXJ1 
positive ciliated cells after 8 days of ALI with or without IL-13 (5 ng/ml) in P1. Nuclei are stained with DAPI (blue). Scale 
bar: 30 µm. 
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2Suppl. Fig. 4. Western blot of Krt14 expression on ALI day 0 in P0 and P2 (a) Expression of Trp63, Krt5, Krt8, Krt14 
and Ngfr mRNA in MTEC Passage (P) 0 and 2 at day 0 of Air Liquid Interfase (ALI) ALI normalized to Gapdh (mean± 
SEM). * p < 0.05 by unpaired t-test (n=4). (b) Full length blots of the cropped blots of fig. 4d. Beta-Actin (ACTB) is used 
ad loading control and labeled on the same blot as KRT5. (c) Full length blots of the cropped blots of fig. 4f. ACTB is 
used ad loading control and labeled on the same blot as KRT14.
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Pediatric lung diseases, such as congenital diaphragmatic hernia (CDH) and 
congenital pulmonary airway malformations (CPAM), often result from aberrant 
regulation of lung progenitor cells in their maintenance, proliferation or differentiation 
fate during development. Upon birth and in later life, it is equally important that 
residing progenitor cells are correctly regulated for homeostasis and repair after 
injury. For example, premature newborns require respiratory support to sufficiently 
oxygenate the blood. But due to the exposure of high oxygen by mechanical 
ventilation, the premature lungs are damaged and children can develop a clinical 
entity called Bronchopulmonary Dysplasia (BPD). This shows that proper repair by 
progenitor cells is important. It is thought that progenitor cells often activate identical 
processes during regeneration as those required for development. With this in mind 
and described in this thesis, we developed mouse and human airway in vitro models 
to study progenitor cell behavior. Furthermore we studied responses of different 
airway progenitor populations and the regulation of the transcription factors SOX2 
and SOX21 in maintenance, proliferation and differentiation of airway progenitor 
cells. In this chapter we will discuss the potential mechanisms that contribute to 
SOX2+SOX21+ airway progenitor cell behavior, and the in vitro models that are 
being used to study airway progenitor cell function. Moreover we will reflect on the 
potential consequences of our findings in future clinical treatment strategies.
SOX2 AND SOX21 COORDINATE CELL FATE-DETERMINING 
TRANSCRIPTIONAL EVENTS  
Intrinsic cellular changes occur as SOX2+ airway progenitor cells differentiate to 
airway specific cell types. Complete loss of SOX2 in airway epithelium results in a 
loss of basal cells, a decrease in cilia and secretory cells, during development and 
during regeneration [1]. In addition to the importance of SOX2 in airway progenitor 
differentiation, SOX2 is critical for pluripotency in embryonic stem cells and 
development of many other organs, e.g. brain, intestine and esophagus [2-4]. SOX2 
is co-expressed with SOX21 in only some progenitor cells, e.g. in airway (chapter 
4), inner ear, neuron, and embryonic stem cells [5-8]. Due to the widespread role 
of SOX2, its function is subject of multiple studies, but the interaction of SOX2 
with SOX21 on progenitor cell behavior has mostly been ignored. In chapter 4, 
we showed that SOX2 and SOX21 have opposite effects on airway progenitor cell 
differentiation: SOX2 stimulates and SOX21 inhibits differentiation. We proposed that 
they regulate a balance in maintenance and turnover of airway progenitor cells. In 
chapter 5 we show that deficiency in SOX2 and SOX21 have opposite phenotypes 
in clustering neuroendocrine (NE) cells during development. Thus, it seems that 
SOX2 and SOX21 stimulate and repress sets of genes in an opposite manner to 
influence airway development and regeneration. 
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The level of expression of SOX2 and SOX21 determines progenitor cell 
behavior 
Common among stem-, progenitor-, and pluripotent- cells is their sensitivity to 
changes in SOX2 dosage [9, 10]. A notable difference among these tissues is the 
effect of SOX2 expression levels on either proliferation or differentiation. Neural 
progenitor cells exit the cell cycle upon Sox2 deletion [11], while trachea epithelium 
exhibit altered differentiation programs without changes in cell proliferation (chapter 
4). The high dosage depency of the regulatory function of SOX2 was nicely illustrated 
in neuronal progenitor cells. At high levels, SOX2 occupied low affinity binding sites 
to repress Ccnd1 expression, while at low levels SOX2 was also found at high-
affinity binding sites to activate Ccnd1 [11]. In chapter 4, we showed that in vitro 
SOX2 and SOX21 levels increase during human and mouse basal cell differentiation, 
suggesting a dosage dependent regulatory function for both proteins. Like SOX2 
transcriptional targets of SOX21 might also be dosage dependent, and may interfere 
with SOX2-induced genes, due to its conserved DNA binding domain and potential 
binding to SOX2 [8, 9] (Fig. 1).  
Fig. 1. (A) Representative SOX proteins of group B1 and B2 are shown. Group B of the SOX protein family is subdivided 
into subgroup B1(activators) and B2 (repressors). Similarity score of the HMG domain amino acid (aa) sequence is 
relative to SOX2. Between subgroups B1 and B2, the similarities is found in ‘Group B homology’ besides the HMG 
domain [76].   (B) During the differentiation of airway progenitor cells and basal cells, SOX protein levels can fluctuate 
and competition can cause either transcription or repression of genes involved in differentiation. This figure illustrates 
a few examples on how this can influence gene transcription in relation to SOX2 and SOX21. (C) SOX2 can induce 
genes involved in differentiation, like TRP63 (chapter 4), but requires the binding of additional co-factors for active 
transcription. (D) SOX21 can interfere with this transcription to form a complex with SOX2, so additional factors cannot 
bind. This can either occur bound to the DNA (shown) or not bound to the DNA (not shown). (E) Another possibility is 
that, upon increasing levels of SOX21, SOX21 competes with SOX2 DNA binding by either binding to other additional 
cofactors (Y) or even by competing with similar co-factors (X) that bind SOX2.   
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The importance of SOX2 dosage is further shown by a defect in the separation 
of trachea and esophagus early in development at decreased levels of SOX2 [4]. 
Upon separation Sox2, but also Sox21 was increased 7 fold in the esophagus when 
compared to the trachea, suggesting that an early mechanism of SOX2 and SOX21 
regulation of genes might be important in a correct separation [12]. However Sox21-/- 
mice do not show a defect in separation of the esophagus and trachea. Furthermore, 
Sox21-/- mice show an increased differentiation of airway progenitor cells, but does 
not cause any respiratory distress. Thus SOX21 may fine-tune SOX2 function, and 
be important in maintaining a progenitor state, but probably does not regulate sets of 
genes that are essential for the development of the esophagus, trachea or airways. 
Because Sox21-/- mice show increased differentiation, it would be interesting to 
pursue the effect of SOX21 on ageing of progenitor cells, as a higher turnover of 
progenitor populations might result in respiratory dysfunction later in life through 
depletion of the progenitor pool and thus homeostasis. Generating a conditional 
knock-out (KO) mouse of Sox21 in airway epithelium would provide a model to study 
the effect of SOX21 on ageing of the lung specifically. In chapter 4, Sox21+/- mice 
did not show increased regeneration of airway epithelium compared to wild-type. An 
airway specific conditional Sox21 KO would provide further opportunities to study 
the effect of complete loss of SOX21 on airway specific injury, which is currently not 
possible due to the fragility of the Sox21-/- mouse. 
Cofactors of SOX2 and SOX21 determine their regulatory function 
How SOX2 and SOX21 regulate cell fate in individual cells depends further on the 
identity of its co-factors. SOX proteins alone do not elicit their action, but require 
binding to other transcription factors that provide specificity [9, 13, 14]. A number of 
putative SOX2 binding partners were identified in E18.5 lung using a mouse model 
containing a biotinylated SOX2 [15]. It would be interesting to identify co-factors that 
have the potential to bind SOX2 and SOX21, and thereby regulating transcription 
or repression of genes by forming a complex with either one. This might explain 
some of the contradicting phenotypes of increased or decreased differentiation upon 
loss of SOX2 or SOX21 respectively (chapter 4 and 5). Several hypotheses may 
explain this opposite effect, for example; (1) SOX2 and SOX21 can interact with 
each other, preventing additional binding of SOX2 or SOX21 to other co-factors, 
or (2) they have similar DNA binding motifs and bind similar co-factors due to their 
homology,, which would in a competition in both binding to the DNA and/or to their 
co-factors (Fig. 1B-E). As described previously, binding of SOX2 or SOX21 to DNA 
is dosage dependent. Similarly, the binding to their co-factors or each other might 
also be dosage dependent. Visualizing the interaction between SOX2 and SOX21 
could be studied by the formation of a fluorescent complex when two non-fluorescent 
fragments are brought together [16]. The possibility to insert such fluorescent 
fragments into the SOX2 and SOX21 gene would provide the potential visualization 
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of the SOX2-SOX21 interaction within individual cells during development by live 
cell imaging and tissue clearing, or during adult progenitor differentiation in either 
air-liquid interface (ALI) or airway organoid cultures. 
Determining co-factors of SOX2 and SOX21, is important to understand the 
mechanisms underlying changes in progenitor function resulting in airway 
malformations or disturbed differentiation. An example of an identified binding partner 
of SOX2 is the chromatin remodeling helicase CHD7. While SOX2 is associated with 
AEG (Anaphtalmia-EsophagealGenital)-syndrome, CHD7 is linked to CHARGE-
syndrome (Coloboma, Heart malformations, Atresia of the choanae, Retarded 
growth, Genital anomalies and Ear anomalies). Clinical variation between these two 
syndromes frequently causes a failed diagnosis of these patients. The interaction 
between SOX2 and CHD7 provides a molecular explanation of the phenotypic 
gradient displayed by AEG and CHARGE patients and provides a connection 
between these at first sight genetic unrelated diseases [13]. SOX2 and SOX21 are 
often co-expressed in various progenitor cells and the identification of their common 
co-factors might also provide a link between now seemingly unrelated diseases, 
as seen in AEG and CHARGE syndrome. Identifying downstream targets of SOX2 
and SOX21 and determining their co-factors is likely to provide a link between the 
underlying mechanisms causing congenital lung anomalies.  
Both, squamous cell carcinoma (SQSC) originating from basal cells, and small cell 
lung cancer (SCLC) originating from NE cells, have been shown to have increased 
levels of SOX2 and/or SOX21 [17,19]. SOX proteins themselves are not druggable, 
hence identifying their targets would potentially help to develop new therapeutic 
strategies. Furthermore, interaction partners identified in SQSC, have been shown to 
be interaction partners of SOX2 in basal cells of healthy tissue [20]. The identification 
of co-factors of SOX2 and SOX21 with mass-spectrometry is difficult in low cell 
numbers or for specific cell types, therefore the use of cell lines originating from 
SCLC or SQSC with high expression levels of SOX2 and SOX21 may help to identify 
interacting partners in the normal development, homeostasis or differentiation of 
basal and NE cells.
In conclusion, identification of co-factors or DNA binding sites of SOX2 and SOX21, 
in a cell type specific manner and upon different dosages of SOX2 or SOX21 is a 
challenging perspective for future research. Recent methodology of single-cell RNA 
sequence provides a cell specific signature which could be related to expression 
levels of Sox2 and Sox21 [21]. In chapter 4, we showed that SOX2 and SOX21 
levels differ in subsets of cells using previously published single cell RNA sequencing 
of human primary bronchial epithelial cells. Combining RNA sequencing, with ATAC-
sequencing would provide a way to identify regulatory regions that direct transcription 
of cell-type specific genes [22]. Doing these experiments in airway specific cells 
depleted of SOX2, SOX21 or both, using either transgenic mice or siRNA mediated 
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depletion, would provide insight in the effect of loss of SOX2 and/or SOX21 on 
specific gene sets. In addition, with novel Chromatin Immunoprecipitation (CHIP) 
methodologies, less input material is needed which provides opportunities to study 
targets of SOX2 and SOX21 on possible FACS sorted specific cells. In future, a 
single-cell CHIP strategy might even be possible [23].
EXTRINSIC SIGNALING CUES COORDINATE LINEAGE DECISIONS AND THE 
MICROENVIRONMENT OF PROGENITOR CELLS 
Cells undergo various differentiation, trans-differentiation and de-differentiation 
programs during development and regeneration, often regulated by the local 
tissue microenvironment. During development, different progenitors are present 
along the branching airways from the proximal to distal end and a subset of the 
adult progenitor cells remain in the epithelium at specific locations; submucosal 
glands, tracheal epithelium and neuroendocrine cells. Distinct niche components, 
including mesenchymal cells, neighboring epithelial cells, nerves, immune cells and 
extracellular matrix, can contribute to progenitor cell behavior, during development 
and from quiescence airway epithelium to active regeneration (Fig. 2). 
Mesenchymal-epithelial signaling define the extrapulmonary airways 
SOX21+ airway epithelium localizes with the presence of basal cells during 
development and in adult airway epithelium (chapter 4). Distal mesenchymal 
FGF10 signaling inhibits differentiation of SOX9+ tip progenitor cells early in 
lung development, but once epithelial cells are committed to the SOX2+ airway 
epithelium, FGF10 can also induce basal cell differentiation [24]. SOX21 might 
identify this proximal epithelial region where basal cell differentiation is induced and 
where underlying FGF10 signaling is present. In adult tracheal epithelium, basal 
cells maintain themselves and are recruited upon injury by mesenchymal expression 
of FGF10 (Fig. 2A). The secretion of FGF10 is regulated by epithelial activation of 
the Hippo pathway effector, YAP, leading to the expression and secretion of Wnt7b 
[25-27] (Fig 1A). YAP expression is essential for the maintenance of TRP63+ basal 
cells and loss of YAP results in increased differentiation to ciliated cells [26]. YAP 
regulates SOX2 expression in the transition from distal to proximal epithelium early 
in lung development [28]. Vice versa, SOX2 was shown to regulate transcription 
of YAP in cancer cells and osteo-adipo lineages [29, 30]. As SOX2 and SOX21 
provides a balance between maintenance and differentiation of basal cells, it could 
well be that SOX2 and SOX21 are involved in transcription or silencing of YAP in 
basal cell differentiation and thereby influencing mesenchymal FGF10 signaling. 
Mutations in the FGF10 gene are associated to an airway branch variation with high 
odds on the development of Chronic Obstructive Pulmonary Disease (COPD) [31]. 
Studying FGF and HIPPO signaling upon deletion of SOX2 and/or SOX21 would 
provide a potential link between SOX2, SOX21 and FGF10 signaling, which could
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reveal potential novel ways of targeting COPD.
Notch signaling in airway epithelium guides differentiation 
During development, we observed a heterogeneous expression of especially 
SOX21 within the airway epithelium (chapter 4 and 5). Notch signaling, is known 
for being expressed in a salt-and-pepper pattern, where receptor (Notch1 to Notch4) 
and ligand (Jag1, Jag2, Dll1, Dll3 and Dll4) are expressed from neighboring cells 
and influence cell fate decisions during organ development [32]. Inhibition of the 
Notch signaling pathway, increases the differentiation to ciliated and NE cells at the 
expense of secretory cells [33] (Fig. 2B). Jag2 shows a similar expression pattern 
as SOX21: starting proximal around E12.5 and from E13.5 onward it overlaps with 
the SOX2+ SOX21+ extrapulmonary airways, while Jag1 is only expressed in the 
SOX2+ intrapulmonary airways [34].  Within the inner ear and neurogenesis, SOX2 
and SOX21 are linked to Notch activity by either regulating transcription of Jag1 
and Notch responsive gene Hes5 [5, 6, 13, 35]. SOX2 and SOX21 might regulate 
transcription of multiple Notch factors, like Jag1 and Jag2, in extrapulmonary 
airways, as well as Hes1 in the development of Neuroendocrine (NE) and non-NE 
cell fate. Furthermore, the increase in NE precursor cells upon loss of SOX21, is 
similar to the phenotype observed by a loss of Dll ligands (chapter 4 and 5) [1, 
34]. This would suggest that both SOX2 and SOX21 do not only target a single 
Notch pathway, but may actually regulate multiple Notch and non-Notch signaling 
pathways dependent on airway specific cell type, which can be a subject for future 
studies. Investigating the expression of SOX2 and SOX21 upon complete inhibition 
of the Notch pathway (Rbpj or Pofut1 KO) or upon specific deletion of ligands or 
receptors can further establish whether SOX2 or SOX21 are up- or down-stream 
of Notch signaling. A complex role for Notch signaling, as both tumor suppressor 
or pro-tumorigenic, is defined in SCLC [36]. As, SOX2 and SOX21 are upregulated 
in a subset of SCLC, a potential link between Notch function and development of 
SCLC in relation with SOX2 or SOX21 might provide novel biomarkers to stratify the 
observed heterogeneity in SCLC.
Neuronal innervation influences progenitor cell differentiation 
During the formation of the respiratory tract, an associated neural network is formed 
[37-39]. At the end of lung development, neurons innervate airway smooth muscle 
cells to control smooth muscle tone and trigger reflexes such as cough, but also 
innervate the SOX2+SOX21+  airway epithelium (Fig. 2C and 3A) , submucosal 
glands [40, 41] and NE cells (chapter 5, Fig. 2C). In chapter 5, we showed that the 
first histological sign of innervation of NE cells occurs around E16.5 and corresponds 
with a dip in SOX2 and SOX21 protein levels. During development of the salivary 
gland, it was shown that maintaining Sox2 expression is dependent on innervation 
[42]. Such a role between Sox2 expression and neuronal innervation has not yet
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Fig. 2. Around SOX2+SOX21+ airway epithelium, trachea, submucosal glands and neuroendocrine cells, different 
cellular (mesenchymal-, epithelial-, neuronal- and immune- cells) and non-cellular components (extracellular matrix) 
contribute to the behavior of progenitor cells. (A) HIPPO-WNT-FGF reciprocal signaling between basal and underlying 
stromal cells, contribute to the maintenance of basal cells in the tracheal epithelium. Upon injury, damaged epithelium 
secrete WNT7B and FGF10 is secreted from Smooth muscle actin positive (SMA+) fibroblasts, which recruit basal 
cells to regenerate the epithelium. (B) Notch signaling guides differentiation of basal cells to secretory (Notchhigh) or 
ciliated (Notchlow) cells. A subset of neuroendocrine (NE) cells in a NE cluster in Notch2+, and is suggested to function 
as a stem cell. Upon injury, the NE dedifferentiate to a transit amplifying cells under control of high Notch signaling. 
This transit amplifying cell subsequently differentiates to ciliated or secretory cells, probably also through receiving 
a high or low notch signal [73]. (C) The tracheal epithelium and neuroendocrine cells are innervated by neurons. 
Stimulation of NE can lead to the secretion of factors that might act on corresponding receptors present on the airway 
epithelium or can increase immune infiltrates [48, 74, 75]. Basal cells contain the P75-neuronal growth factor receptor 
(NGFR), which, potentially is stimulated by secretion of NGF by neuronal cells. However, this pathways has not yet 
been studied in the airway epithelium (D) Extracellular matrix (ECM) proteins are underlying the airway epithelial cells. 
Airway epithelial cells interact with ECM protein through integrin receptors, upon damage these interactions might 
change, which can influence progenitor cell behavior. 
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been explored in the airway epithelium.
Defective innervation of respiratory epithelium has been associated with the 
development of EA/TEF [43], as well as to branching defects in a CDH animal 
model [44]. Furthermore, disrupting neuronal innervation by laser ablation in explant 
cultures, resulted in a failure of local budding, suggesting involvement of neuronal 
innervation in the formation of the airway tree [45]. In the salivary gland, innervation 
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has shown to be essential in maintaining the undifferentiated state of progenitor 
cells during development and regeneration [46, 47].  In future, explant culture 
with neuronal ablation or adding inhibitors of neuronal secretion could be used to 
specifically study the effect of innervation on progenitor cell differentiation during 
development and regeneration. 
Immune cells increase complexity to regulation of airway progenitor behavior 
In the lung, infiltration of immune cells correlates with lung diseases. It is known 
that basal cells and NE cells, both innervated, can have a function in the immune 
response and recruitment of immune cells [48-50]. In bronchopulmonary dysplasia 
(BPD), immune infiltration and NE cell hyperplasia is observed, but an interaction 
between neuronal innervation, immune response and onset of disease have has not 
yet been explored.  
The infiltration of immune cells is a hallmark of tissue under stress, but they also 
have been thought as components that drive stem cell behavior within homeostatic 
conditions [51]. Macrophages have been shown to support stem cell survival in the 
intestine and regulatory T cells are found near the stem cell niche of hair follicles 
and promote regeneration [52, 53]. We (chapter 2 and 3) have shown that upon 
exposure of the inflammatory cytokine IL-13, basal cells differentiate to goblet cells at 
the cost of ciliated cells. However, the interaction between immune cells and airway 
progenitor cell differentiation under homeostatic conditions have yet to be explored. 
The complexity of different cell types and their interaction between immune cells and 
other cells during lung development was recently studied by single cell sequencing 
of complete mouse lung tissues at various time points. Subsequently, the study 
examined ligand-receptor pairs between cell types in a spatial-temporal manner to 
map cellular interactions during development [54]. Most, interactions were found 
within the immune compartment and sporadic interactions were found between 
the immune and non-immune compartment, but these might include key signaling 
pathways for tissue development and homeostasis [54]. In future, immune cell- 
epithelial cell interactions during development, but also homeostasis, need to be 
confirmed and immunodeficient mouse models could help to identify the contribution 
of immune cells to progenitor cell fate decisions in the future. 
The role of the extracellular matrix in the airway progenitor niche 
Extracellular matrix (ECM) components can play a key part in determining cell 
fate during development and regeneration (Fig. 2D). The lung ECM continuously 
remodels during development [55], but the response of progenitor cells during 
development to ECM has not been studied well in the developing lung. The 
difference in dorsal-to-ventral localization of SOX2+SOX21+ airway epithelium early 
in lung development (chapter 4), could be due to difference in ECM composition, 
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in addition to differences in the mesenchymal population. Such a key role for cell-
ECM interactions was demonstrated in the developing pancreas, where progenitors 
that encounter a laminin- or collagen-enriched environment results in endocrine 
differentiation, while progenitors exposed to a fibronectin- or vitronectin- enriched 
ECM maintain their progenitor state [56]. 
Several chronic respiratory diseases, including idiopathic pulmonary fibrosis, asthma, 
and chronic obstructive pulmonary disease (COPD), are associated with aberrant 
or excessive composition of ECM proteins. Besides immune infiltration, BPD also 
shows decreased vascularization, simplification of the alveolar compartment and a 
discomposed ECM [55, 57]. A key role was demonstrated for TGF-β in the remodeling 
of the ECM in a BPD animal model, and basal cells exposed to TGF-β can be a 
source of aberrant ECM production [58, 59]. Furthermore, production of matrix 
metalloproteinases by basal cells to remodel the ECM was shown to be essential 
for complete epithelial regeneration in vivo and differentiation towards the ciliated 
cell fate [60]. Studying the interaction between ECM components and progenitor cell 
behavior can help define therapeutic targets, but can also improve in vitro airway 
models to guide differentiation or to exactly mimic the physiological conditions found 
in vivo.
IN VITRO AIRWAY MODELLING TO STUDY AIRWAY PROGENITOR BEHAVIOR 
IN RELATION TO (CONGENITAL) AIRWAY DISEASES 
Novel in vitro models provide an opportunity to study the different components 
contributing to progenitor behavior and can further bridge the knowledge gap between 
the findings made in animal models and human airway epithelium. Additionally, 
airway models resembling the in vivo environment freshly derived from patient 
material may further provide patient-specific cultures, which can be used for personal 
drug screening or sensitivity or identification of biomarkers. The risk of developing 
BPD in individual premature newborns which received oxygen supplementation and 
mechanical ventilation is difficult to predict. Comparing tracheal aspirates, either 
directly or after establishing airway-specific cultures, of premature newborns that 
develop BPD with those that do not develop BPD, will be especially be relevant for 
identification of biomarkers. The cultures would also be beneficial in providing the 
opportunity to gain mechanistic insight. For example, immune regulatory functions 
of basal cells in air-liquid interface cultures could be studied and compared between 
children that develop BPD and children that do not.
Studying lung development in vitro 
The development of specific culture conditions for organoids, opens opportunities in 
studying human airway development and congenital lung diseases [61]. In chapter 
4, we used fetal lung tip organoids, to compare the expression pattern of SOX21 in 
mouse to human lung development. In addition, specific airway organoid medium, 
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made it possible to culture airway organoids using primary tissue of CPAM patients 
(Fig. 3B). These primary cultures, make it possible to study CPAM versus healthy 
airway epithelial cells, as well as studying the effect of the mesenchymal populations 
on these cells. In future, combining healthy or CPAM epithelial cells with healthy or 
CPAM mesenchymal cells offers an opportunity to separate the epithelial intrinsic from 
the mesenchymal contribution to organoid formation. Despite these developments, 
human primary tissue is scarce and often difficult to genetically modify, therefore 
necissitating alternatives to study human lung development.
Fig. 3. (A) The upper pictures 
show NGFR+ basal cells (red) in 
SOX21+ (green) human airway  
epithelium. In the lower figure, 
Synaptic Vesicle 2 (SV2) shows 
neuronal innervation of human 
airway epithelium. Scalebar = 50 
µm. (B,C) Brightfield images from 
airway organoids obtained from 
lung resection material of a CPAM 
patient. Healthy lung material was 
obtained from healthy resection 
material, and CPAM was obtained 
from cystic lung tissue. P = 
passage number. Scale bar = 100 
µm. 
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Differentiation of human pluripotent stem cells into specific airway epithelial cells, 
like basal or neuroendocrine cells [62, 63], shows the potential to study every step 
of differentiation separately and further explore the role of SOX2 and SOX21 at each 
step. Using organoid cultures, it is possible to mimic different parts of the human 
lung, like the airway, alveolar compartment or even lung bud organoids [64, 65]. 
Furthermore, the lung bud organoids, which not only resemble the proximal-distal 
pattern of human branching morphogenesis, also contained the lung mesodermal 
lineage [66]. Despite some limitations, e.g. lack of vascular cells, this culture 
system provides a tool to study human lung development, epithelial-mesenchymal 
interactions and opens opportunities to study lung progenitor behavior with the use 
of genetically modified (human) pluripotent stem cells.  
Although these cultures show the potential of studying airway development, they lack 
neighboring compartments during lung specification.  A recent experiment, where a
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posterior foregut spheroid was transferred adjacent to an anterior foregut spheroid, 
showed that without adding exogenous factors, the spheroids fused and start 
developing markers of biliary duct, pancreas and liver [67]. This specification of 
different organs by itself, would be interesting to study in respect to the separation 
of esophagus and trachea early in development, and how it goes awry in children 
born with EA/TEF.  
Studying adult airway progenitors in vitro 
With the use of in vivo lineage tracing studies, injury models and in vitro culturing, 
it became apparent that the airway epithelium contains a remarkable cellular 
plasticity. Dedifferentiation of mouse secretory cells to basal cells, with subsequent 
differentiation into full functional airway epithelium after injury was observed in vivo 
and in vitro [68]. We suggested in chapter 3 that luminal cells obtained from either 
bronchoalveolar lavage (BAL) or tracheal aspirate (TA), also dedifferentiate in vitro 
to form airway organoids. However, we observed that basal cells obtained from 
the BAL and TA are less potent than basal cells obtained from primary bronchial 
tissue directly. Several questions remain: (1) is there indeed a dedifferentiation 
of luminal cells and (2) are dedifferentiated basal cells different from basal cells 
directly obtained from primary tissue? With the use of intestinal organoids, it was 
observed that both sorted LGR5+ (intestinal stem cells) and LGR5- cells can form 
intestinal organoids [69]. A similar separation of lung basal and non-basal cells in 
future would provide an opportunity to study dedifferentiation of luminal cells in vitro. 
This would allow a direct comparison between basal cells and dedifferentiated basal 
cells from the same tissue with respect to their gene expression patterns, epigenetic 
modifications, and response to simulations, like smoke exposure, Notch inhibition 
and IL-13 exposure. 
By studying human airway diseases in vitro, we mostly depend on the availability 
of human primary tissue. With the use of organoid (3D) and culture plastic (2D) 
expansion, we show that air-exposed cultures can be derived from several sources, 
but that cultures differ in their response not only with respect of their source but also 
to their expansion method (chapter 3). Furthermore, it is important to realize that 
culturing basal cells may induce phenotypic changes, as is observed by an enrichment 
in KRT14+ basal cells in chapter 2. As for the study of human diseases, patient 
specific characteristics are of importance, and the effects of culturing cells should 
not be ignored. However, a recent study shows that strong intrinsic characteristics 
of basal cells, are being retained upon culture [70]. We also observed growth 
differences of primary cells obtained from cystic structures or healthy tissue of CPAM 
patients in culture (Fig. 3B), suggesting that some patient-specific characteristics 
are maintained. A challenge for future research will be to identify specific airway 
progenitor functions mimicking the in vivo situation rather than researching potential 
in vitro artefacts.
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Due to the generation of airway specific culture media, the interaction between 
airway epithelial cells and other cell types is often ignored as for example, feeder 
cells are no longer needed. As the interaction between different cell types play a 
fundamental role in airway epithelium homeostasis and regeneration (see above), it 
would be important to include these compartments in future airway models [71, 72]. 
CONCLUDING REMARKS 
Within this thesis, we elaborated on the understanding of airway progenitor 
behavior within airway development and regeneration. We identified, that changes 
in expression levels of SOX2 and SOX21 can influence the balance in progenitor 
maintenance and differentiation. Understanding the molecular mechanisms up- 
and down- stream of these two SOX transcription factors, might especially be of 
importance in the development of chronic airway or congenital lung diseases. The 
influence of SOX2 and SOX21 in progenitor function described in chapter 4 and 
their upregulation in specific types of lung cancers, opens opportunities to further 
relate their function to tumor formation and progression and the potential findings of 
new therapeutic targets. We provided an in vitro model to study the airway epithelial 
compartment in relation to BPD for the first time through the development of human 
airway disease specific cultures, such as the tracheal aspirate from premature 
newborns (chapter 3). This can further contribute to the identification of biomarkers 
or understanding of disease progression. Furthermore, in chapter 5, we showed 
preliminary data of the contribution of SOX2 and SOX21 in the development of NE 
cells and using these models in future might help to understand NE cell function, for 
example, in the onset of CDH. 
Finally, understanding airway progenitor functions and their niche in vivo will be 
essential for mimicking the human lung in vitro. In the future, regenerative medicine 
by either cell transplantation, or creating transplantable organs in vitro, might 
provide therapy for end-stage lung disease. Either synthetic (3D-printed) scaffolds 
or de-cellularised ECM scaffolds, combined with re-cellularisation with autologous 
progenitor cells, may lead to fully functional transplantable organs in the future. 
Although, such approaches might be far away in the future for lung diseases, the 
identification of specified SOX21+ SOX2+ airway regions, as well as the generation 
of novel in vitro airway models will contribute to the improvement of current protocols 
in the generation of lung specific cells types for clinical applications.   
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A
SUMMARY 
Congenital lung diseases, like congenital diaphragmatic hernia and congenital 
pulmonary airway malformations, are often associated with an aberrant differentiation 
of endodermal progenitor cells. In addition, upon birth and later in life, proper airway 
progenitor function is important for maintaining airway epithelium homeostasis and 
preventing lung diseases. Both intrinsic and extrinsic mechanisms control progenitor 
maintenance, either by transcriptional regulation or by extracellular signals from 
the progenitor niche. Within these mechanisms, an overlap in airway progenitor 
function can be found during airway development, homeostasis and adult airway 
regeneration. This thesis describes the development and usage of in vitro and in 
vivo models to study the transcription factors SOX2 and SOX21 in airway progenitor 
function during development and regeneration.  
In chapter 2, culture conditions are defined to expand mouse tracheal epithelial 
cells (MTECs), for the establishment of air-liquid interface (ALI) culture. In this way, 
a method was established to study the differentiation of basal cells to secretory- 
and ciliated cells with a limited number of mice. Despite the possibility to expand 
MTECs, a decreased differentiation of basal cells to ciliated cells was observed. This 
decreased differentiation potential was related to a shift in basal cell population, from 
a KRT14 negative population without expansion, to a KRT14 positive population 
with expansion. The decreased differentiation in basal cells to ciliated cells could be 
improved by prolonging the ALI-induced differentiation or by the inhibition of Notch 
signaling, suggesting that basal cells did retain their ability to differentiate.  
In chapter 3, the possibility to use organoids for the expansion of a low number 
of human airway epithelial cells (AECs) obtained from available clinical sources 
was investigated. These organoids, were subsequently cultured on ALI system 
to develop a more relevant air-exposed model to study airway epithelial function. 
First, it was shown that the expansion method of AECs from bronchial tissue (BT), 
either as organoid- or the conventional 2D method, does not change ALI-induced 
differentiation. Next, ALI-induced differentiation, cigarette smoke induced ER stress 
and response to IL-13 and Notch inhibition, on organoid expanded AECs obtained 
from different sources; tracheal aspirate (TA), bronchoalveolar lavage (BAL) and BT 
was compared. From all sources, well-differentiated ALI cultures, containing basal, 
ciliated and secretory cells, could be established. However, BAL and TA derived 
ALI cultures showed to be less responsive to IL-13 and Notch inhibition, compared 
to BT derived ALI cultures. It was suggested that, when the source of AECs is 
absent in basal cells, like the TA and BAL but not BT, luminal cells de-differentiate 
to basal cells in organoid culture but do not regain all basal cell functionality. The 
potential to use this method to culture and expand limited number of cells present 
in TA of neonates, provides for the first time a humanized model to study the 
potential involvement of AECs in the development of bronchopulmonary dysplasia. 
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Chapter 4 describes that high levels of SOX2 during airway development coincides 
with expression of SOX21 in the trachea and main bronchi.  This newly defined 
SOX2+ and SOX21+ region, overlaps with the differentiation of progenitor cells to 
basal- and neuroendocrine (NE) cells (chapter 5). By the use of mouse models 
deficient in either SOX2 or SOX21, it was shown that SOX2 stimulates and 
SOX21 suppresses airway progenitor differentiation during both development and 
regeneration of the extrapulmonary airways. In addition, SOX21 influenced SOX2 
induced differentiation, by antagonizing SOX2 on different promotors involved in 
differentiation. The use of human fetal lung organoids and human adult airway ALI 
culture showed that SOX2 and SOX21 expression is conserved in human airway 
development.  
In chapter 5, the function of SOX2 and SOX21 in a small subpopulation of airway 
epithelial cells, the NE cell was explored. Here, a distinct role for both SOX2 and 
SOX21 was observed at different stages of NE development. SOX21 suppresses 
differentiation of SOX2+ airway progenitors to NE cells, while deficiency in SOX2 
only causes a delay in maturation of NE cells during development. Both, SOX2 and 
SOX21, were involved in the clustering of NE cells and show opposite phenotypes; 
deficiency of SOX2 resulted in more single solitary NE cells, while deficiency of SOX21 
resulted in a higher percentage of NE cells present in clusters. This preliminary work 
is the start of understanding the basic mechanisms of how NE cell development is 
regulated and might contribute to the understanding of NE hyperplasia, which is 
associated with several lung disease. 
In chapter 6, the main results and their contribution to the field of airway progenitor 
cell function, (congenital) airway diseases and in vitro culture models are discussed. 
In conclusion, this thesis presents novel in vitro models to study airway epithelial 
function and shows that slight changes in expression pattern of SOX2 and SOX21 
can disturb airway development and regeneration.  
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A
SAMENVATTING 
De oorzaak van congenitale longaandoeningen, zoals Congenitale Hernia 
Diafragmatica en Congenitale pulmonale luchtwegafwijkingen, is vaak geassocieerd 
met een defect in de differentiatie van long voorlopercellen. Ook wanneer de longen 
volgroeid zijn, is het belangrijk dat luchtweg voorlopercellen goed functioneren om 
een homeostase van het luchtwegepitheel te behouden en aandoeningen aan de 
luchtwegen te voorkomen. Het behouden van de voorlopercel of het differentiëren 
naar andere luchtweg specifieke cellen, wordt gecontroleerd door intracellulaire 
veranderingen en extracellulaire signalering, die aanwezig is in de niche van de 
voorlopercellen. Er is een overlap in de mechanismes van luchtweg voorlopercel 
functie tijdens ontwikkeling van de luchtwegen en homeostase en regeneratie van 
het luchtwegepitheel. In dit proefschrift zijn in vitro en in vivo modellen gebruikt 
om de functie van transcriptiefactoren SOX2 en SOX21 te bestuderen in luchtweg 
voorlopercellen tijdens de ontwikkeling en regeneratie. 
In hoofdstuk 2, zijn kweekcondities gegenereerd om muis tracheaal epitheelcellen 
(MTEC) te expanderen en vervolgens te laten differentiëren op een lucht 
geëxposeerde (airliquid interfase (ALI)) kweek. Hierdoor, kon met een minimaal aantal 
muizen, de differentiatie van basaal cellen naar secretoire- en gecillieerde-cellen 
worden bestudeerd. Het exanderen van MTEC, ging samen met een verminderde 
differentiatie naar gecilieerde cellen en een verrijking in een subpopulatie van basaal 
cellen, die positief zijn voor Keratine 14 (KRT14+). Deze verminderde differentiatie 
naar gecilieerde-cellen kon verbeterd worden door de tijd van de ALI-kweek te 
verlengen of door een remmer van de Notch signalering toe te voegen. Dit suggereert 
dat ondanks de verrijkingen van KRT14+ basaal cellen, ze de potentie behouden om 
te differentiëren.  
In hoofdstuk 3, werd de mogelijkheid onderzocht om organoïden te gebruiken om 
luchtweg epitheelcellen (LEC) te expanderen. Deze organoïden, werden vervolgens 
gekweekt op een ALI-systeem om een relevanter lucht geëxposeerd model te creëren. 
Eerst is er aangetoond dat de expansiemethode van LEC verkregen van bronchiaal 
weefsel (BW), de conventionele 2D methode of door het gebruiken van organoïden, 
niet de differentiatie op de ALI kweek beïnvloedt. Vervolgens, werden LEC verkregen 
van tracheaal aspiraten (TA), bronchie-alveolaire lavage (BAL) en BW, in organoïds 
geëxpandeerd en op ALI-kweek gezet. De ALI-geïnduceerde differentiatie, ER 
stress geïnduceerd door sigaretten rook en respons op IL-13 en Notch inhibitie, werd 
vergeleken tussen deze kweken. De ALI-kweek van alle bronnen bevatte een gelijke 
hoeveelheid aan basaal-, gecilieerde- en secretoire-cellen. Desondanks, reageerde 
de BAL en TA opgezette ALI-kweken verminderd op blootstelling aan IL-13 of 
Notch inhibitie, dit in vergelijking met de BW opgezette ALI-kweken. Dit effect wordt 
mogelijk gecreëerd doordat TA en BAL maar niet BW, origineel geen basaal cellen 
bevatten en dat eerst luminale-cellen moeten de-differentiëren naar basaal cellen in
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de organoïde kweek. Deze ge-de-differentieerde basaal cellen verkrijgen vervolgens 
niet alle basaal voorlopercel potentie. In dit hoofdstuk, zijn wij de eerste die een 
model laten zien om LEC te bestuderen uit TA afkomstig van prematuur geboren 
kinderen. Dit is vooral van belang om te onderzoeken wat de rol van LECs zijn in de 
ontwikkeling van bronchopulmonaire dysplasie.  
In hoofdstuk 4 werd laten zien dat hoge niveaus van SOX2 expressie tijdens de 
ontwikkeling van de luchtwegen samengaat met de expressie van SOX21 in de 
trachea en de hoofd bronchi. Deze nieuw gedefinieerde SOX2+ SOX21+ regio gaat 
samen met de differentiatie van voorlopercellen naar basaal- en neuro-endocrine 
(NE)- cellen (hoofdstuk 5). Met het gebruik van muismodellen, die minder SOX2 of 
SOX21 tot expressie brengen, werd laten zien dat SOX2 belangrijk is in het stimuleren 
van differentiatie terwijl SOX21 de differentiatie van luchtweg voorlopercellen 
remt. SOX21 beïnvloedt de SOX2 geïnduceerde differentiatie door SOX2 functie 
te inhiberen bij het activeren van verschillende promotoren die betrokken zijn bij 
de differentiatie van voorlopercellen. Door humane foetale organoïden en humane 
volwassen luchtweg ALI kweken te gebruiken, is er aangetoond dat de expressie 
van SOX2 en SOX21 geconserveerd is in humaan luchtwegepitheel.  
In hoofdstuk 5 werd de functie van SOX2 en SOX21 verder bestudeerd in een kleine 
subpopulatie van luchtweg epitheelcellen, de NE-cellen. Verschillende SOX2 en 
SOX21 functies in de verschillende stadia van NE-cel ontwikkeling is in dit hoofdstuk 
beschreven. SOX21 remt de differentiatie van SOX2+ luchtweg voorlopercellen naar 
NE cellen, terwijl SOX2 vooral belangrijk is in de maturatie van NE cellen. Beide, 
SOX2 en SOX21, spelen een rol in het clusteren van NE-cellen; minder SOX2 liet 
meer enkele NE-cellen in de luchtweg zien, terwijl minder SOX21 leidde tot meer 
NE-cellen in clusters. Het preliminaire werk gepresenteerd in dit hoofdstuk is een 
start in het begrijpen van de basale mechanismes betrokken bij NE-cel ontwikkeling 
en kan bijdragen aan het begrijpen van NE cel hyperplasie, die aanwezig is in een 
verschillend aantal (congenitale) longaandoeningen.   
In hoofdstuk 6, zijn de hoofdresultaten en hun bijdrage in het veld van luchtweg 
voorlopercellen, (congenitale) longaandoeningen en in vitro kweekmodellen 
bediscussieerd.  
Tot slot, dit proefschrift presenteert nieuwe in vitro modellen om luchtweg 
epitheelfunctie te onderzoeken en laat zien dat kleine veranderingen in 
expressieniveaus van SOX2 en SOX21 kan leiden tot een afwijkende luchtweg 
ontwikkeling en luchtweg regeneratie.
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Appendix 185
A
PHD PORTFOLIO
Seminar and workshops   
Monday morning weekly work discussions Cell Biology 2014-2019 2 
MGC PhD workshop, Maastricht        2015  1 
PhD meeting Cell Biology Department       2016-2018 1 
Weekly Lab meeting            2014-2019 2 
Bi-weekly Journal club           2014-2019 1 
MGC PhD workshop, Leuven         2017  1 
Monthly ACE-PH meeting        2017-2018 1 
(Inter)national conferences 
NRS meeting: Animal models in science, Utrecht    2013  1 
Longdagen, Utrecht            2015  1 
NRS meeting: Young Inverstigator Symposium (presentation) 
Amsterdam 
2016  1 
Organoid meeting, Cambridge, UK        2017  2 
GRC lung development, injury and Repair(poster), New London, 
USA 
2017   2 
European Pediatric Surgeons’ Association (presentation), Belgrade, 
Serbia  
2019  2 
MGC Sypmposia (presentation), Rotterdam     2019  2 
Themeday (presentation), Rotterdam       2019  1 
Courses
Biochemistry and Biophysics           2014  3 
Genetics                2014  3 
Laboratory animal sciences (Article 9)        2015  3 
Scientific Integrity             2015  0,3 
Microscopic image analysis: from theory to practice    2015  0,8 
Ensemble Gene Browsing course          2015  0,6 
English Biomedical Writing and Communications     2017  3 
Biostatistical methods I: Basic Principles Part A      2017  2 
Practical Linux course            2017  0,4 
Safely working in Laboratory         2018  0,3 
Teaching
Supervision Master student Molecular Medicine 5
Supervision Master student Molecular Medicine      5 
Supervision Bachelor Student Practical Laboratory School 4 
Supervision Bachelor Student Practical Laboratory School 4 
Supervision Bachelor Student Practical Laboratory School 4 
External Committee member thesis defence Hogeschool Rotterdam 1 
Total 60,4
